{
  "directed": true,
  "graph": {
    "annotation_list": {},
    "annotation_pattern": {
      "Species": "^\\d+$"
    },
    "annotation_url": {
      "Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
      "CellStructure": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "Disease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno"
    },
    "document_metadata": {
      "authors": "Trusha Adeshara",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright © 2019 Fraunhofer Institute SCAI, All rights reserved.",
      "description": "",
      "licenses": "CC BY 4.0",
      "name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis",
      "version": "1.0.0"
    },
    "namespace_pattern": {
      "NCIT": "^C\\d+$",
      "PUBCHEM": "^\\d+$"
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/chebi-names.belns",
      "CONSO": "https://raw.githubusercontent.com/pharmacome/conso/4aa36980578c7d2cff07371abf768f15db89cd11/export/conso-names.belns",
      "DOID": "https://raw.githubusercontent.com/pharmacome/conso/c0c576e3d3ab9b25a3982251a4ee2fd7c49e1679/external/doid-names.belns",
      "DRUGBANK": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/drugbank-names.belns",
      "EFO": "https://raw.githubusercontent.com/pharmacome/conso/5d2c2ea6f7112421cc8089a3f021a75ab60bb373/external/efo-names.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/conso/d9d270e11aac480542c412d4222983a5f042b8ae/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc-names.belns",
      "HGNCGENEFAMILY": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/hgnc.genefamily-names.belns",
      "HP": "https://raw.githubusercontent.com/pharmacome/conso/d9d270e11aac480542c412d4222983a5f042b8ae/external/hp-names.belns",
      "INTERPRO": "https://raw.githubusercontent.com/pharmacome/conso/c328ad964c08967a0417a887510b97b965a62fa5/external/interpro-names.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/conso/0816cb6686751420365441adc6a28ced2d272f14/external/mesh-names.belns",
      "MGI": "https://raw.githubusercontent.com/pharmacome/conso/efc856fb009a39e4d284269a6801f79ed3d3cf56/external/mgi-names.belns"
    },
    "path": "ms/wang2019.bel",
    "pybel_version": "0.14.10"
  },
  "links": [
    {
      "annotations": {
        "Anatomy": {
          "perivascular space": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Choroid Plexus": true,
          "Meninges": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "The CNS contains several resident macrophages, such as microglia and non-parenchymal macrophages, in the choroid plexus, perivascularspace,and meninges,which function to maintain CNS homeostasis(Prinzetal.,2011).",
      "key": "f3a64adb3db14fa7bdfe7a69d17189e7",
      "line": 81,
      "relation": "regulates",
      "source": 32,
      "target": 75
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Studies have demonstrated that microglia mediate synaptic pruning and trophic-factor production through fractalkine-CX3CR1 signaling in neurodevelopment (Tremblay et al., 2010; Ransohoﬀ and El Khoury, 2014; Schafer and Stevens, 2015; Miyamoto et al., 2016)",
      "key": "9ef2e07bb047fdaf93c539cf6bafc597",
      "line": 117,
      "relation": "increases",
      "source": 32,
      "target": 81
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Studies have demonstrated that microglia mediate synaptic pruning and trophic-factor production through fractalkine-CX3CR1 signaling in neurodevelopment (Tremblay et al., 2010; Ransohoﬀ and El Khoury, 2014; Schafer and Stevens, 2015; Miyamoto et al., 2016)",
      "key": "c3f941bee71f3f9ff3efb43655920b43",
      "line": 120,
      "relation": "increases",
      "source": 32,
      "target": 72
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "In addition, microglial-secreted BDNF could increase the activity of neuronal tropomyosin-related kinase receptor B, an important modulator in synaptic plasticity,prompting a crucial role of BDNF signaling in learning and memory-related synapse formation (Parkhurst etal.,2014).",
      "key": "cd63387d2f12baec9f3bbb64196888d5",
      "line": 150,
      "relation": "increases",
      "source": 32,
      "target": 72
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Although microglia are important in synaptic plasticity, this function is destroyed under pathological insults,which causes synaptic loss in MS and eventually, cognitive decline (Michailidou et al., 2015; Hong et al., 2016; Salter and Stevens, 2017; Di Filippo et al., 2018).",
      "key": "46d0999a15a451bcdcd930830b3ef66f",
      "line": 376,
      "relation": "increases",
      "source": 32,
      "target": 72
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Although microglia are important in synaptic plasticity, this function is destroyed under pathological insults,which causes synaptic loss in MS and eventually, cognitive decline (Michailidou et al., 2015; Hong et al., 2016; Salter and Stevens, 2017; Di Filippo et al., 2018).",
      "key": "0acdd206fbfc0a885c982e66bbb5d651",
      "line": 378,
      "relation": "decreases",
      "source": 32,
      "target": 72
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Studies have demonstrated that microglia mediate synaptic pruning and trophic-factor production through fractalkine-CX3CR1 signaling in neurodevelopment (Tremblay et al., 2010; Ransohoﬀ and El Khoury, 2014; Schafer and Stevens, 2015; Miyamoto et al., 2016)",
      "key": "9861157b7249f5a8afeefe5d420be1da",
      "line": 121,
      "relation": "increases",
      "source": 32,
      "target": 55
    },
    {
      "annotations": {
        "Anatomy": {
          "cerebral cortex": true
        },
        "Cell": {
          "neuron": true
        },
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Fractalkine receptor deﬁcient mice showed decreased neuron survival in layer V cortical neurons during the ﬁrst postnatal week because of the reduced secretion of insulin-like growth factor from microglia (Ueno et al., 2013).",
      "key": "c77b2a3ce8378bec3f5b12b1331a9749",
      "line": 131,
      "relation": "increases",
      "source": 32,
      "target": 103
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Furthermore, microglia depletion by the Cre-Lox technique led to deﬁciencies in multiple learning tasks, as well as a signiﬁcant reduction in learning related synapse formation (Parkhurst et al., 2014).",
      "key": "72c4e70dd2b93ebfc68d385798987560",
      "line": 140,
      "relation": "increases",
      "source": 32,
      "target": 57
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Furthermore, microglia depletion by the Cre-Lox technique led to deﬁciencies in multiple learning tasks, as well as a signiﬁcant reduction in learning related synapse formation (Parkhurst et al., 2014).",
      "key": "d4f9a20349171224b5e9509025a1c571",
      "line": 141,
      "relation": "increases",
      "source": 32,
      "target": 13
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "In addition, microglial-secreted BDNF could increase the activity of neuronal tropomyosin-related kinase receptor B, an important modulator in synaptic plasticity,prompting a crucial role of BDNF signaling in learning and memory-related synapse formation (Parkhurst etal.,2014).",
      "key": "a13300135fc839fd9a38aeb1757ce54b",
      "line": 147,
      "relation": "increases",
      "source": 32,
      "target": 85
    },
    {
      "key": "372ef8b024a4aa48d9a5678089643466",
      "relation": "partOf",
      "source": 32,
      "target": 82
    },
    {
      "annotations": {
        "Anatomy": {
          "adult central nervous system": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Moreover, microglia act as scavengers in the adult CNS to remove damaged components, apoptotic cells, and misfolded proteins (Sierra et al., 2010).",
      "key": "c46efdfdaabd679401374d32762786fe",
      "line": 168,
      "relation": "increases",
      "source": 32,
      "target": 46
    },
    {
      "annotations": {
        "Anatomy": {
          "adult central nervous system": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Moreover, microglia act as scavengers in the adult CNS to remove damaged components, apoptotic cells, and misfolded proteins (Sierra et al., 2010).",
      "key": "b24d17d8d13541b5c69d23e0738c92bf",
      "line": 169,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 32,
      "target": 134
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "M1 macrophages and microglia are potent APCs, causing an adaptive immune response to clear foreign substances and abnormal proteins (Das et al., 2015).",
      "key": "5d28ab1356fe4ce66b757563a660d64d",
      "line": 278,
      "relation": "decreases",
      "source": 32,
      "target": 134
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "M1 macrophages and microglia are characterized by an amoeboid shape, and they release pro-inﬂammatory cytokines, such as IL-6, IFN-γ, IL-23, TNF-α; inducible nitric oxide synthase; chemokines, including CCL 4, CCL5, and CCL8; and CXCL 2, CXCL4, and CXCL9 (Juhas et al., 2015; Kapellos and Iqbal, 2016).",
      "key": "0b64484e15209b513f93c1cb95524b80",
      "line": 256,
      "relation": "increases",
      "source": 32,
      "target": 111
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Microglia also secrete a series of pro-inﬂammatory cytokines such as IL-18, IL-6, and IL-1b and chemokines like CCL2 and CCL5 to aggravate both MS and EAE (Merson et al., 2010; Jiang et al., 2014).",
      "key": "d72a6926dc94819c218c33e5f9ebac14",
      "line": 454,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 32,
      "target": 111
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "M1 macrophages and microglia are characterized by an amoeboid shape, and they release pro-inﬂammatory cytokines, such as IL-6, IFN-γ, IL-23, TNF-α; inducible nitric oxide synthase; chemokines, including CCL 4, CCL5, and CCL8; and CXCL 2, CXCL4, and CXCL9 (Juhas et al., 2015; Kapellos and Iqbal, 2016).",
      "key": "ca0c0be501da31c8be97d422faa22103",
      "line": 257,
      "relation": "increases",
      "source": 32,
      "target": 102
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "M1 macrophages and microglia are characterized by an amoeboid shape, and they release pro-inﬂammatory cytokines, such as IL-6, IFN-γ, IL-23, TNF-α; inducible nitric oxide synthase; chemokines, including CCL 4, CCL5, and CCL8; and CXCL 2, CXCL4, and CXCL9 (Juhas et al., 2015; Kapellos and Iqbal, 2016).",
      "key": "8884aa16a43e89fb940bea22de8a0337",
      "line": 258,
      "relation": "increases",
      "source": 32,
      "target": 129
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "M1 macrophages and microglia are characterized by an amoeboid shape, and they release pro-inﬂammatory cytokines, such as IL-6, IFN-γ, IL-23, TNF-α; inducible nitric oxide synthase; chemokines, including CCL 4, CCL5, and CCL8; and CXCL 2, CXCL4, and CXCL9 (Juhas et al., 2015; Kapellos and Iqbal, 2016).",
      "key": "a7003eecb1dffbd38503f139f936447a",
      "line": 259,
      "relation": "increases",
      "source": 32,
      "target": 118
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "M1 macrophages and microglia are characterized by an amoeboid shape, and they release pro-inﬂammatory cytokines, such as IL-6, IFN-γ, IL-23, TNF-α; inducible nitric oxide synthase; chemokines, including CCL 4, CCL5, and CCL8; and CXCL 2, CXCL4, and CXCL9 (Juhas et al., 2015; Kapellos and Iqbal, 2016).",
      "key": "423d6d24e9e36ac88bdf780076e31476",
      "line": 260,
      "relation": "increases",
      "source": 32,
      "target": 112
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "M1 macrophages and microglia are characterized by an amoeboid shape, and they release pro-inﬂammatory cytokines, such as IL-6, IFN-γ, IL-23, TNF-α; inducible nitric oxide synthase; chemokines, including CCL 4, CCL5, and CCL8; and CXCL 2, CXCL4, and CXCL9 (Juhas et al., 2015; Kapellos and Iqbal, 2016).",
      "key": "7889d5873f51a4d411be69af6eedeb96",
      "line": 261,
      "relation": "increases",
      "source": 32,
      "target": 89
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "M1 macrophages and microglia are characterized by an amoeboid shape, and they release pro-inﬂammatory cytokines, such as IL-6, IFN-γ, IL-23, TNF-α; inducible nitric oxide synthase; chemokines, including CCL 4, CCL5, and CCL8; and CXCL 2, CXCL4, and CXCL9 (Juhas et al., 2015; Kapellos and Iqbal, 2016).",
      "key": "4d9c5c7c141a41e1b77bbee0e7b64864",
      "line": 262,
      "relation": "increases",
      "source": 32,
      "target": 90
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Microglia also secrete a series of pro-inﬂammatory cytokines such as IL-18, IL-6, and IL-1b and chemokines like CCL2 and CCL5 to aggravate both MS and EAE (Merson et al., 2010; Jiang et al., 2014).",
      "key": "6b06a7f7a14f1294ae5953502369dcf0",
      "line": 457,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 32,
      "target": 90
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "M1 macrophages and microglia are characterized by an amoeboid shape, and they release pro-inﬂammatory cytokines, such as IL-6, IFN-γ, IL-23, TNF-α; inducible nitric oxide synthase; chemokines, including CCL 4, CCL5, and CCL8; and CXCL 2, CXCL4, and CXCL9 (Juhas et al., 2015; Kapellos and Iqbal, 2016).",
      "key": "451b0717311ec595a6344ab2f2f70d8f",
      "line": 263,
      "relation": "increases",
      "source": 32,
      "target": 91
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "M1 macrophages and microglia are characterized by an amoeboid shape, and they release pro-inﬂammatory cytokines, such as IL-6, IFN-γ, IL-23, TNF-α; inducible nitric oxide synthase; chemokines, including CCL 4, CCL5, and CCL8; and CXCL 2, CXCL4, and CXCL9 (Juhas et al., 2015; Kapellos and Iqbal, 2016).",
      "key": "1fffba3da8039da257cb5e8597564d51",
      "line": 264,
      "relation": "increases",
      "source": 32,
      "target": 98
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "M1 macrophages and microglia are characterized by an amoeboid shape, and they release pro-inﬂammatory cytokines, such as IL-6, IFN-γ, IL-23, TNF-α; inducible nitric oxide synthase; chemokines, including CCL 4, CCL5, and CCL8; and CXCL 2, CXCL4, and CXCL9 (Juhas et al., 2015; Kapellos and Iqbal, 2016).",
      "key": "6b9e07e4e15dad1be638a6d2fa292170",
      "line": 265,
      "relation": "increases",
      "source": 32,
      "target": 115
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "M1 macrophages and microglia are characterized by an amoeboid shape, and they release pro-inﬂammatory cytokines, such as IL-6, IFN-γ, IL-23, TNF-α; inducible nitric oxide synthase; chemokines, including CCL 4, CCL5, and CCL8; and CXCL 2, CXCL4, and CXCL9 (Juhas et al., 2015; Kapellos and Iqbal, 2016).",
      "key": "614d6a6408b0fec69fc2ef5b9f313c2e",
      "line": 266,
      "relation": "increases",
      "source": 32,
      "target": 99
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "M1 macrophages and microglia are potent APCs, causing an adaptive immune response to clear foreign substances and abnormal proteins (Das et al., 2015).",
      "key": "704139b412e41c75d3531d4505d70b1a",
      "line": 272,
      "relation": "isA",
      "source": 32,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Although microglia and inﬁltrating macrophages are potent APCs in EAE, the expression levels of MHC II and costimulatory molecules on microglia are lower (Brendecke and Prinz, 2015), indicating that inﬂammation in the CNS is mainly activated by inﬁltrating macrophages.",
      "key": "fbccbb6af5f74ef190cfc8ff8a97d06e",
      "line": 777,
      "relation": "isA",
      "source": 32,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "M1 macrophages and microglia are potent APCs, causing an adaptive immune response to clear foreign substances and abnormal proteins (Das et al., 2015).",
      "key": "ed5e23d3e8ebb19165dd7c57274ff0b0",
      "line": 275,
      "relation": "increases",
      "source": 32,
      "target": 69
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "In contrast, M2 macrophages and microglia have smaller cell bodies and a branched structure(RansohoﬀandPerry,2009),and they express a variety of anti-inﬂammatory molecules, including IL-4, IL-10, IL-13, and transforming growth factor-β (David and Kroner, 2011).",
      "key": "5ed2d9e14c4e5e39b094e9354ea1b0f5",
      "line": 287,
      "relation": "increases",
      "source": 32,
      "target": 110
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "In contrast, M2 macrophages and microglia have smaller cell bodies and a branched structure(RansohoﬀandPerry,2009),and they express a variety of anti-inﬂammatory molecules, including IL-4, IL-10, IL-13, and transforming growth factor-β (David and Kroner, 2011).",
      "key": "e633a81a4909db79d0d10f52569c6fb6",
      "line": 288,
      "relation": "increases",
      "source": 32,
      "target": 104
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "In contrast, M2 macrophages and microglia have smaller cell bodies and a branched structure(RansohoﬀandPerry,2009),and they express a variety of anti-inﬂammatory molecules, including IL-4, IL-10, IL-13, and transforming growth factor-β (David and Kroner, 2011).",
      "key": "1a3c682c906edf404822198b93b28afc",
      "line": 289,
      "relation": "increases",
      "source": 32,
      "target": 106
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "In contrast, M2 macrophages and microglia have smaller cell bodies and a branched structure(RansohoﬀandPerry,2009),and they express a variety of anti-inﬂammatory molecules, including IL-4, IL-10, IL-13, and transforming growth factor-β (David and Kroner, 2011).",
      "key": "e895b308de3a5e329dc84e5d75cb632e",
      "line": 290,
      "relation": "increases",
      "source": 32,
      "target": 117
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "These contribute to immunoregulation by inhibiting inﬂammation, remodeling tissue, promoting angiogenesis, and clearing parasites (Banerjee et al., 2013).",
      "key": "2c5cb81b8605741008df59f7089efdc2",
      "line": 304,
      "relation": "regulates",
      "source": 32,
      "target": 76
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "These contribute to immunoregulation by inhibiting inﬂammation, remodeling tissue, promoting angiogenesis, and clearing parasites (Banerjee et al., 2013).",
      "key": "089f12f1e7efad804e545d192098f3d3",
      "line": 305,
      "relation": "decreases",
      "source": 32,
      "target": 144
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "These contribute to immunoregulation by inhibiting inﬂammation, remodeling tissue, promoting angiogenesis, and clearing parasites (Banerjee et al., 2013).",
      "key": "96f2b57050cb84b4914a243542b49330",
      "line": 306,
      "relation": "increases",
      "source": 32,
      "target": 64
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "These contribute to immunoregulation by inhibiting inﬂammation, remodeling tissue, promoting angiogenesis, and clearing parasites (Banerjee et al., 2013).",
      "key": "38d5a8c6c20dece27308ee4236a246a5",
      "line": 307,
      "relation": "increases",
      "source": 32,
      "target": 65
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "These contribute to immunoregulation by inhibiting inﬂammation, remodeling tissue, promoting angiogenesis, and clearing parasites (Banerjee et al., 2013).",
      "key": "4344a7689a64c2d0ee1df1c78a710805",
      "line": 308,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 32,
      "target": 36
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "M2 microglia promote oligodendrocyte diﬀerentiation, and their depletion inhibits remyelination (Kotter et al., 2005; Miron et al., 2013).",
      "key": "f3504832158f6adeb61f471b93fb4b0b",
      "line": 314,
      "relation": "increases",
      "source": 32,
      "target": 62
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "M2 microglia promote oligodendrocyte diﬀerentiation, and their depletion inhibits remyelination (Kotter et al., 2005; Miron et al., 2013).",
      "key": "6b0581b6ea6732ac4ff7bd357710bc40",
      "line": 315,
      "relation": "increases",
      "source": 32,
      "target": 78
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Under steady state, microglia are primarily responsible for supporting the development of the healthy brain, they shape and maintain the neuronal synaptic network, interact with neurons and produce beneﬁcial components (Hagemeyer et al., 2017).",
      "key": "32f9f0f8c183d3d8cb428ddac18cb5f3",
      "line": 320,
      "relation": "increases",
      "source": 32,
      "target": 47
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Under steady state, microglia are primarily responsible for supporting the development of the healthy brain, they shape and maintain the neuronal synaptic network, interact with neurons and produce beneﬁcial components (Hagemeyer et al., 2017).",
      "key": "71109c779fde930abb2f0e3584cd6e6c",
      "line": 321,
      "relation": "regulates",
      "source": 32,
      "target": 71
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Although microglia are important in synaptic plasticity, this function is destroyed under pathological insults,which causes synaptic loss in MS and eventually, cognitive decline (Michailidou et al., 2015; Hong et al., 2016; Salter and Stevens, 2017; Di Filippo et al., 2018).",
      "key": "bba007020ff072be9019f16a25d11650",
      "line": 379,
      "relation": "decreases",
      "source": 32,
      "target": 66
    },
    {
      "key": "30acfa3e4ce52b790875ae94af7cbf6e",
      "relation": "partOf",
      "source": 32,
      "target": 80
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Microglia also secrete a series of pro-inﬂammatory cytokines such as IL-18, IL-6, and IL-1b and chemokines like CCL2 and CCL5 to aggravate both MS and EAE (Merson et al., 2010; Jiang et al., 2014).",
      "key": "6268a95666cdd88c955f855fe472f84d",
      "line": 453,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 32,
      "target": 107
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Microglia also secrete a series of pro-inﬂammatory cytokines such as IL-18, IL-6, and IL-1b and chemokines like CCL2 and CCL5 to aggravate both MS and EAE (Merson et al., 2010; Jiang et al., 2014).",
      "key": "acdf1c2481b4103432968beafc7f70ec",
      "line": 455,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 32,
      "target": 109
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Microglia also secrete a series of pro-inﬂammatory cytokines such as IL-18, IL-6, and IL-1b and chemokines like CCL2 and CCL5 to aggravate both MS and EAE (Merson et al., 2010; Jiang et al., 2014).",
      "key": "d0182efa429082894bed0aae74092cdb",
      "line": 456,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 32,
      "target": 87
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "In conclusion, microglia exert detrimental functions in MS and strongly damage myelin.",
      "key": "b114d295e9787dd7b449e7cdca489ec7",
      "line": 477,
      "relation": "increases",
      "source": 32,
      "target": 138
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "In conclusion, microglia exert detrimental functions in MS and strongly damage myelin.",
      "key": "51f8dd1dd385eab375fa495dde8b85a7",
      "line": 478,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 32,
      "target": 19
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Microglial activation may also be beneﬁcial for remyelination in MS due to the phagocytotic ability of microglia, as well as their secretion of neuroprotective molecules and antiinﬂammatory cytokines (Du et al., 2017).",
      "key": "5f3973331227e8ad518cbf3f741b81c8",
      "line": 485,
      "relation": "increases",
      "source": 32,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Microglial activation may also be beneﬁcial for remyelination in MS due to the phagocytotic ability of microglia, as well as their secretion of neuroprotective molecules and antiinﬂammatory cytokines (Du et al., 2017).",
      "key": "e7a56353bec77c63af6bb0a500fb2649",
      "line": 487,
      "relation": "increases",
      "source": 32,
      "target": 77
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "Parkinson's disease": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Other research showed that inﬁltrated CD163+ macrophages in brains from a Parkinson’s disease model modulate local microglia to promote neuroprotection.",
      "key": "ac070cc1e8a622b6e3339fd89346607c",
      "line": 858,
      "relation": "increases",
      "source": 32,
      "target": 77
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Microglial activation may also be beneﬁcial for remyelination in MS due to the phagocytotic ability of microglia, as well as their secretion of neuroprotective molecules and antiinﬂammatory cytokines (Du et al., 2017).",
      "key": "72fd72ae0280fa753fe7b7ed81b04174",
      "line": 488,
      "relation": "increases",
      "source": 32,
      "target": 28
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "In contrast to microglia, macrophages express TREM-1 rather than TREM-2,and although this isoform plays a role in inﬂammatory responses (Colonna and Facchetti,2003),the functions of TREM1 still need to be further studied in a CNS autoimmunity context.",
      "key": "a2cd427aa90f08be34b5b68ad48ddd59",
      "line": 629,
      "relation": "increases",
      "source": 32,
      "target": 122
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Studies have found that the neuroprotective eﬀects of glatiramer acetate are mediated by activated M2 microglia (Ratchford et al., 2012).",
      "key": "43c56f62054f3cce5874f77a1c2f7e28",
      "line": 803,
      "relation": "increases",
      "source": 32,
      "subject": {
        "modifier": "Activity"
      },
      "target": 17
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Alterations in CNS homeostasis lead to the recruitment of peripheral blood-derived monocytes (known as monocyte-derived macrophages) into the CNS, the activation of microglia, and the presence of foamy macrophages (Bogie et al., 2014; Kuhlmann et al., 2017; Mrdjen et al., 2018; Zéphir, 2018).",
      "key": "a94f1d8ed92316fd3d7029e409614324",
      "line": 90,
      "relation": "increases",
      "source": 75,
      "target": 33
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Alterations in CNS homeostasis lead to the recruitment of peripheral blood-derived monocytes (known as monocyte-derived macrophages) into the CNS, the activation of microglia, and the presence of foamy macrophages (Bogie et al., 2014; Kuhlmann et al., 2017; Mrdjen et al., 2018; Zéphir, 2018).",
      "key": "a18ef8a30b8e0fffdb9ad4406d4f064f",
      "line": 91,
      "relation": "increases",
      "source": 75,
      "target": 59
    },
    {
      "annotations": {
        "Anatomy": {
          "perivascular space": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Choroid Plexus": true,
          "Meninges": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "The CNS contains several resident macrophages, such as microglia and non-parenchymal macrophages, in the choroid plexus, perivascularspace,and meninges,which function to maintain CNS homeostasis(Prinzetal.,2011).",
      "key": "f31e2688da196a977b93b6bd8797bc08",
      "line": 82,
      "relation": "regulates",
      "source": 31,
      "target": 75
    },
    {
      "annotations": {
        "Cell": {
          "neuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Monocyte-derived macrophages and CNS-resident phagocytic cells can promote neuroinﬂammation, thereby inducing MS, but they can also play neuroprotective and anti-inﬂammatory roles, depending on many factors.",
      "key": "e8d5372def72afba0d9772a10e0b3ecb",
      "line": 98,
      "relation": "increases",
      "source": 31,
      "target": 60
    },
    {
      "annotations": {
        "Cell": {
          "neuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Monocyte-derived macrophages and CNS-resident phagocytic cells can promote neuroinﬂammation, thereby inducing MS, but they can also play neuroprotective and anti-inﬂammatory roles, depending on many factors.",
      "key": "976f74a17aacbee3d43f7772a1c4e048",
      "line": 100,
      "relation": "increases",
      "source": 31,
      "target": 138
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Monocyte-derived macrophages and CNS-resident phagocytic cells can promote neuroinﬂammation, thereby inducing MS, but they can also play neuroprotective and anti-inﬂammatory roles, depending on many factors.",
      "key": "c062ecbd44a8f5973cade6a777285575",
      "line": 102,
      "relation": "increases",
      "source": 31,
      "target": 77
    },
    {
      "annotations": {
        "Anatomy": {
          "perivascular space": true
        },
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Substantial evidence indicates that perivascular macrophages have both supportive and neuroprotective roles in MS.",
      "key": "3833f31c5e3479cea91ebbfab0fd15bf",
      "line": 658,
      "relation": "increases",
      "source": 31,
      "target": 77
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "Parkinson's disease": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Other research showed that inﬁltrated CD163+ macrophages in brains from a Parkinson’s disease model modulate local microglia to promote neuroprotection.",
      "key": "4b0ec50bede4395a7321bc9ec52d8e60",
      "line": 859,
      "relation": "increases",
      "source": 31,
      "subject": {
        "location": {
          "name": "Brain",
          "namespace": "MESH"
        }
      },
      "target": 77
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Monocyte-derived macrophages and CNS-resident phagocytic cells can promote neuroinﬂammation, thereby inducing MS, but they can also play neuroprotective and anti-inﬂammatory roles, depending on many factors.",
      "key": "339ddeb30f1240aa3a5bf5726f560fd0",
      "line": 103,
      "relation": "decreases",
      "source": 31,
      "target": 144
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Although microglia and inﬁltrating macrophages are potent APCs in EAE, the expression levels of MHC II and costimulatory molecules on microglia are lower (Brendecke and Prinz, 2015), indicating that inﬂammation in the CNS is mainly activated by inﬁltrating macrophages.",
      "key": "e5a5bb580b68929a476be050223f5f47",
      "line": 780,
      "relation": "increases",
      "source": 31,
      "target": 144
    },
    {
      "annotations": {
        "Anatomy": {
          "perivascular space": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Perivascular macrophages are critical in BBB establishment (Mendes-Jorge et al., 2009; He et al., 2016), and blockage of colony stimulating factor 1 receptor signaling leads to a decreased coverage of pericytes in brain vessels (Yamamotoetal.,2017).",
      "key": "ab891092124ad6b572e48b0e47620141",
      "line": 189,
      "relation": "increases",
      "source": 31,
      "target": 53
    },
    {
      "annotations": {
        "Anatomy": {
          "adult brain": true,
          "perivascular space": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Blood Vessels": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Perivascular macrophages continuously retract and protract along blood vessels in the adult brain (Daneman, 2012; Goldmann et al., 2016), suggesting that they may play a role in immune surveillance.",
      "key": "b8a1a2d42ad1ba1321a20976cead6d4b",
      "line": 202,
      "relation": "increases",
      "source": 31,
      "target": 76
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Meninges": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "In addition, meningeal macrophages function as APCs, detecting cell debris and antigens to maintain immune homeostasis (Kivisakk et al., 2009).",
      "key": "edcfa42e6af73647dc04c412db9547d4",
      "line": 220,
      "relation": "increases",
      "source": 31,
      "target": 76
    },
    {
      "annotations": {
        "Anatomy": {
          "perivascular space": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Moreover, they can protect against bacterial infection by recruiting circulating leukocytes (Polﬂiet et al., 2001).",
      "key": "c62ee31ea8e4d2d538ff8062729aee21",
      "line": 211,
      "relation": "increases",
      "source": 31,
      "target": 18
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Meninges": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "In contrast, meningeal macrophages produce neurotrophic and anti-inﬂammatory factors to inhibit leukocyte activity and their inﬁltration into the CNS at particular disease stages (Bogie et al., 2014).",
      "key": "a896519b7fd49e3bf6bd79a97d7e9a9a",
      "line": 718,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 31,
      "target": 18
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Meninges": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "In contrast, meningeal macrophages produce neurotrophic and anti-inﬂammatory factors to inhibit leukocyte activity and their inﬁltration into the CNS at particular disease stages (Bogie et al., 2014).",
      "key": "fd9ee4e867dc31b4456cdd771da7fd24",
      "line": 721,
      "object": {
        "location": {
          "name": "Central Nervous System",
          "namespace": "MESH"
        }
      },
      "relation": "decreases",
      "source": 31,
      "target": 18
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Meninges": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "In addition, meningeal macrophages function as APCs, detecting cell debris and antigens to maintain immune homeostasis (Kivisakk et al., 2009).",
      "key": "a3c3badb7f356e882bdbdf8c3bc97e0c",
      "line": 218,
      "relation": "isA",
      "source": 31,
      "target": 14
    },
    {
      "annotations": {
        "Anatomy": {
          "perivascular space": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Selective elimination of both perivascular and meningeal macrophages by treatment with clodronate-loaded liposomes reduces the progression of EAE in rats (Polﬂiet et al., 2002), suggesting that perivascular macrophages may act as competent APCs in EAE.",
      "key": "a115a14a3b5318ed2a4e66209989c355",
      "line": 672,
      "relation": "isA",
      "source": 31,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Although microglia and inﬁltrating macrophages are potent APCs in EAE, the expression levels of MHC II and costimulatory molecules on microglia are lower (Brendecke and Prinz, 2015), indicating that inﬂammation in the CNS is mainly activated by inﬁltrating macrophages.",
      "key": "1fec644a6fc26f10b3a0598dc69f242a",
      "line": 778,
      "relation": "isA",
      "source": 31,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Meninges": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "In addition, meningeal macrophages function as APCs, detecting cell debris and antigens to maintain immune homeostasis (Kivisakk et al., 2009).",
      "key": "235f4a847ce9d5c08b03083b76e04c89",
      "line": 219,
      "relation": "decreases",
      "source": 31,
      "target": 41
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Choroid Plexus": true,
          "Microvilli": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Choroid plexus macrophages are located near the microvilli of the choroid plexus (Liddelow, 2015; Marques et al., 2017), and their main function may support CSF release and ﬂux (Goldmannetal.,2016).",
      "key": "e139c284bbe53388896a943f3bb4032a",
      "line": 227,
      "relation": "increases",
      "source": 31,
      "target": 50
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Choroid Plexus": true,
          "Microvilli": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Choroid plexus macrophages are located near the microvilli of the choroid plexus (Liddelow, 2015; Marques et al., 2017), and their main function may support CSF release and ﬂux (Goldmannetal.,2016).",
      "key": "7f09cc241cf7964614abd5522fdbd206",
      "line": 228,
      "relation": "increases",
      "source": 31,
      "target": 49
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Bone marrow chimeric mice show that TRPM2 expressed by CNS-inﬁltrating macrophages prompts the production of CXCL2, thus increasing neutrophil inﬁltration and contributing to the progression of EAE (Tsutsui et al., 2018).",
      "key": "58a0ddd30d5a926fe0ce35dadec3c3cf",
      "line": 573,
      "relation": "increases",
      "source": 31,
      "target": 123
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Macrophages also secrete large amounts of pro-inﬂammatory cytokines, such as IL6, IL-12, TNF-α, IL-1, and IL-23, to aggravate the inﬂammatory response (Valentin-Torres et al., 2016).",
      "key": "c7b7223901ba4ab79039b01cd827bbdb",
      "line": 583,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 31,
      "target": 111
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Macrophages also secrete large amounts of pro-inﬂammatory cytokines, such as IL6, IL-12, TNF-α, IL-1, and IL-23, to aggravate the inﬂammatory response (Valentin-Torres et al., 2016).",
      "key": "21df238303902d0f9001dedfaf3228e6",
      "line": 584,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 31,
      "target": 105
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Macrophages also secrete large amounts of pro-inﬂammatory cytokines, such as IL6, IL-12, TNF-α, IL-1, and IL-23, to aggravate the inﬂammatory response (Valentin-Torres et al., 2016).",
      "key": "b64a227ac0dc289792d2af41f3fdb497",
      "line": 585,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 31,
      "target": 118
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Macrophages also secrete large amounts of pro-inﬂammatory cytokines, such as IL6, IL-12, TNF-α, IL-1, and IL-23, to aggravate the inﬂammatory response (Valentin-Torres et al., 2016).",
      "key": "cddc12b00d7a6d5f69a165577d683896",
      "line": 586,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 31,
      "target": 108
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Macrophages also secrete large amounts of pro-inﬂammatory cytokines, such as IL6, IL-12, TNF-α, IL-1, and IL-23, to aggravate the inﬂammatory response (Valentin-Torres et al., 2016).",
      "key": "6d333fafc7c5384ed684297c16cad537",
      "line": 587,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 31,
      "target": 129
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Macrophages also express high levels of CCR4 during the disease, and CCR4 deletion leading to reduced accumulation of macrophages in CNS and attenuated EAE symptoms(Fordeetal., 2011).",
      "key": "9eaa031039712e9c56973b633cdfc04e",
      "line": 613,
      "relation": "increases",
      "source": 31,
      "target": 92
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "These ﬁndings suggest that macrophages are responsible for demyelination, but their direct functions on axons remain to be determined.",
      "key": "50358daf3e0bef0dcfeea1307525f370",
      "line": 624,
      "relation": "increases",
      "source": 31,
      "target": 141
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "In contrast to microglia, macrophages express TREM-1 rather than TREM-2,and although this isoform plays a role in inﬂammatory responses (Colonna and Facchetti,2003),the functions of TREM1 still need to be further studied in a CNS autoimmunity context.",
      "key": "0e126501a6fa035fea84d2c6584f6ca0",
      "line": 630,
      "relation": "increases",
      "source": 31,
      "target": 121
    },
    {
      "annotations": {
        "Anatomy": {
          "perivascular space": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "EAE related perivascular macrophages upregulate the expression of MHC II and can present peptides to myelin-speciﬁc T cells in the CNS, thereby accelerating disease progression (Perry, 1998; Fabriek et al., 2005; Greter et al., 2005; Vogel et al., 2013).",
      "key": "d6ac5a63da6c09a22c66ca5510f0e9bf",
      "line": 678,
      "relation": "increases",
      "source": 31,
      "target": 128
    },
    {
      "annotations": {
        "Anatomy": {
          "perivascular space": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "EAE related perivascular macrophages upregulate the expression of MHC II and can present peptides to myelin-speciﬁc T cells in the CNS, thereby accelerating disease progression (Perry, 1998; Fabriek et al., 2005; Greter et al., 2005; Vogel et al., 2013).",
      "key": "9013c5b70cfe777d32d37e33eda3e8aa",
      "line": 679,
      "relation": "increases",
      "source": 31,
      "target": 140
    },
    {
      "annotations": {
        "Anatomy": {
          "myelin": true
        },
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Consistent with this, researchers found that mouse myelin macrophages could inhibit IFN-γ release by Th1 cells and suppress EAE severity (Bogie et al., 2014).",
      "key": "ada9515b14aa8a5bcc3def1f44610ae5",
      "line": 770,
      "relation": "decreases",
      "source": 31,
      "target": 140
    },
    {
      "annotations": {
        "Anatomy": {
          "perivascular space": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Furthermore, perivascular macrophages express high levels of adhesion molecules such as VCAM-1 and ICAM-1 and chemokines like CCL2 and CCL3 (Hofmann et al., 2002; Vercellino et al., 2017), which may mediated by chondroitin sulfate proteoglycans (Stephenson et al., 2018), to promote leukocyte inﬁltration into the CNS.",
      "key": "066048ce647b3b0c65b193b769cbd3f1",
      "line": 687,
      "relation": "increases",
      "source": 31,
      "target": 124
    },
    {
      "annotations": {
        "Anatomy": {
          "perivascular space": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Furthermore, perivascular macrophages express high levels of adhesion molecules such as VCAM-1 and ICAM-1 and chemokines like CCL2 and CCL3 (Hofmann et al., 2002; Vercellino et al., 2017), which may mediated by chondroitin sulfate proteoglycans (Stephenson et al., 2018), to promote leukocyte inﬁltration into the CNS.",
      "key": "4eb3dc1c3220e6772cb3dd818d021ac0",
      "line": 688,
      "relation": "increases",
      "source": 31,
      "target": 100
    },
    {
      "annotations": {
        "Anatomy": {
          "perivascular space": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Furthermore, perivascular macrophages express high levels of adhesion molecules such as VCAM-1 and ICAM-1 and chemokines like CCL2 and CCL3 (Hofmann et al., 2002; Vercellino et al., 2017), which may mediated by chondroitin sulfate proteoglycans (Stephenson et al., 2018), to promote leukocyte inﬁltration into the CNS.",
      "key": "8271f91fd2d96dabd4d039f6cd2ff74c",
      "line": 689,
      "relation": "increases",
      "source": 31,
      "target": 87
    },
    {
      "annotations": {
        "Anatomy": {
          "perivascular space": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Furthermore, perivascular macrophages express high levels of adhesion molecules such as VCAM-1 and ICAM-1 and chemokines like CCL2 and CCL3 (Hofmann et al., 2002; Vercellino et al., 2017), which may mediated by chondroitin sulfate proteoglycans (Stephenson et al., 2018), to promote leukocyte inﬁltration into the CNS.",
      "key": "45523daef76a3e34b36f30826897ccd0",
      "line": 690,
      "relation": "increases",
      "source": 31,
      "target": 88
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Meninges": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "In concordance, meningeal macrophages are equipped to present peptide antigens to T cells, triggering neuroinﬂammatory events (Bartholomäus et al., 2009; Kivisakk et al., 2009; Ransohoﬀ and Cardona, 2010).",
      "key": "3dbf24992bd66caea05d34b0e4629266",
      "line": 708,
      "relation": "increases",
      "source": 31,
      "target": 44
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Meninges": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "In contrast, meningeal macrophages produce neurotrophic and anti-inﬂammatory factors to inhibit leukocyte activity and their inﬁltration into the CNS at particular disease stages (Bogie et al., 2014).",
      "key": "265f2781fcc4131b78b82e49162b8082",
      "line": 714,
      "relation": "increases",
      "source": 31,
      "target": 131
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Meninges": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "In contrast, meningeal macrophages produce neurotrophic and anti-inﬂammatory factors to inhibit leukocyte activity and their inﬁltration into the CNS at particular disease stages (Bogie et al., 2014).",
      "key": "37c408b69de797edda12ba5c94c914ee",
      "line": 715,
      "relation": "increases",
      "source": 31,
      "target": 126
    },
    {
      "annotations": {
        "Anatomy": {
          "myelin": true
        },
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Consistent with this, researchers found that mouse myelin macrophages could inhibit IFN-γ release by Th1 cells and suppress EAE severity (Bogie et al., 2014).",
      "key": "656f786735be5fbcbef16c88fb98d86c",
      "line": 769,
      "relation": "decreases",
      "source": 31,
      "target": 102
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "Parkinson's disease": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Other research showed that inﬁltrated CD163+ macrophages in brains from a Parkinson’s disease model modulate local microglia to promote neuroprotection.",
      "key": "6a7cda170610bb35540dca772dbb78c0",
      "line": 857,
      "relation": "regulates",
      "source": 31,
      "subject": {
        "location": {
          "name": "Brain",
          "namespace": "MESH"
        }
      },
      "target": 32
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "After CNS injury and inﬂammation, while microglia situated in the parenchyma and macrophages in the choroid plexus, perivascular space, and the meninges are activated, monocytes from the blood cross the damaged BBB and become monocyte derived macrophages in the CNS (Lassmann et al., 2001).",
      "key": "9da23d579ec0cccf2795263ed4e92a8b",
      "line": 352,
      "object": {
        "location": {
          "name": "Blood-Brain Barrier",
          "namespace": "MESH"
        }
      },
      "relation": "directlyIncreases",
      "source": 33,
      "subject": {
        "location": {
          "name": "Blood-Brain Barrier",
          "namespace": "MESH"
        }
      },
      "target": 31
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Inﬁltrating monocytes accumulate at the nodes of Ranvier during early stages of EAE and actively initiate the demyelination of axons (Yamasakietal.,2014), similar to microglia, but they do not aﬀect CNS-resident microglia (Ajami et al., 2011).",
      "key": "8dc942a8b1d19132e85d3dc6ca964678",
      "line": 564,
      "relation": "increases",
      "source": 33,
      "subject": {
        "location": {
          "name": "node of Ranvier",
          "namespace": "GO"
        }
      },
      "target": 141
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Inﬁltrating monocytes accumulate at the nodes of Ranvier during early stages of EAE and actively initiate the demyelination of axons (Yamasakietal.,2014), similar to microglia, but they do not aﬀect CNS-resident microglia (Ajami et al., 2011).",
      "key": "3cefcc292173a13b6c297163f00b8ec0",
      "line": 566,
      "relation": "causesNoChange",
      "source": 33,
      "target": 32
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Microglia may communicate with neurons;changes in the physiological environment such as chronic stress and light deprivation can cause hyper-ramiﬁcation of microglia and more frequent neuron–microglia contacts (Torres-Platas et al., 2014; Welberg, 2014; Yirmiya et al., 2015).",
      "key": "c2ade942747aaa0ccff18c13255ba528",
      "line": 160,
      "relation": "increases",
      "source": 59,
      "target": 82
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Once “danger” signals are detected in the surrounding environment, microglia rapidly change into a reactive phenotype, characterized by larger soma, and release various complement factors to facilitate neuron and tissue repair (Hanisch and Kettenmann, 2007; Graeber and Streit, 2010; Kettenmannetal.,2011).",
      "key": "f072a544c2ff0c2a3498c06cde6d5934",
      "line": 178,
      "relation": "increases",
      "source": 59,
      "target": 51
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Upon detecting “danger” signals, both microglia and non-parenchymal macrophages produce large amounts of chemokines and cytokines to promote leukocyte inﬁltration into the CNS parenchyma and function as APCs to reactivate T cells in the CNS (Gallietal.,2011;Krausgruber et al.,2011).",
      "key": "63b1c5c50c566197f720993574cde727",
      "line": 329,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 59,
      "target": 27
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Upon detecting “danger” signals, both microglia and non-parenchymal macrophages produce large amounts of chemokines and cytokines to promote leukocyte inﬁltration into the CNS parenchyma and function as APCs to reactivate T cells in the CNS (Gallietal.,2011;Krausgruber et al.,2011).",
      "key": "5e891dfbbcef232312e9c614651c49fb",
      "line": 331,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 59,
      "target": 28
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "These microglia are enriched with iron, express proinﬂammatory cytokines, and cause persistent tissue damage (Wisnieﬀ et al., 2015).",
      "key": "ca54a7cb3a03c9766e0a6d02084c090a",
      "line": 368,
      "relation": "increases",
      "source": 59,
      "target": 28
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Activated microglia in EAE mice may produce large amounts of TNFα and thus induce excessive glutamate, leading to spontaneous and miniature excitatory post-synaptic currents (Centonze et al., 2009, 2010).",
      "key": "f91b8c1f86768e417e3402911b9eb980",
      "line": 386,
      "relation": "increases",
      "source": 59,
      "target": 118
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Activated microglia in EAE mice may produce large amounts of TNFα and thus induce excessive glutamate, leading to spontaneous and miniature excitatory post-synaptic currents (Centonze et al., 2009, 2010).",
      "key": "6e334eadb9f22e8ad865da48572e2202",
      "line": 389,
      "relation": "increases",
      "source": 59,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Furthermore, astroglial ATP ampliﬁes microglial signals and subsequently promotes glutamate release from astroglia, which directly inhibits synaptic transmission (Kettenmann et al., 2013).",
      "key": "25d2fc3a06781a149a6d6a4673307cbc",
      "line": 396,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "Astrocytes",
            "namespace": "MESH"
          },
          "toLoc": {
            "name": "Synapses",
            "namespace": "MESH"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 59,
      "target": 0
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Importantly, mitochondrial disturbances have been demonstrated in modulating MS lesions,reactive oxygen species and reactive nitrogen species generated by the activated microglia also lead to intra-axonal mitochondrial injury (Balaban et al., 2005;Haileetal.,2017).",
      "key": "f51a3c7d957a8db45d8805b16d2c2460",
      "line": 418,
      "relation": "increases",
      "source": 59,
      "target": 21
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Importantly, mitochondrial disturbances have been demonstrated in modulating MS lesions,reactive oxygen species and reactive nitrogen species generated by the activated microglia also lead to intra-axonal mitochondrial injury (Balaban et al., 2005;Haileetal.,2017).",
      "key": "a9c3b3e9684ac486ec2604b11025e8f1",
      "line": 419,
      "relation": "increases",
      "source": 59,
      "target": 20
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "However, speciﬁc deletion of MHCII in microglia does not aﬀect disease progression,suggesting that microglia are not important in reactivating eﬃcient T cells in the CNS (Wolf et al., 2018).",
      "key": "5ef2f42318dfcc06fe559d6b0fea7167",
      "line": 447,
      "relation": "causesNoChange",
      "source": 59,
      "target": 44
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Microglial activation may also be beneﬁcial for remyelination in MS due to the phagocytotic ability of microglia, as well as their secretion of neuroprotective molecules and antiinﬂammatory cytokines (Du et al., 2017).",
      "key": "be75d91fafe4ce99a4ea1e83526fb142",
      "line": 484,
      "relation": "increases",
      "source": 59,
      "target": 78
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Several receptors, including TREM2, complement receptor 3, and signal regulatory protein-α, invoke microglia to phagocytose myelin debris in lesions (Brendecke and Prinz, 2015).",
      "key": "855c7bd6ba6d4ede15f61f060a003ca2",
      "line": 507,
      "relation": "increases",
      "source": 59,
      "target": 68
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Moreover, microglia secrete trypsinogen, insulin-like growth factor, and ﬁbroblast growth factor during activation to promote neurogenesis (Pérez-Martín et al., 2010; Voss et al., 2012).",
      "key": "0b407cceff38dac486c0d14d9a33cfb6",
      "line": 522,
      "relation": "directlyIncreases",
      "source": 59,
      "target": 83
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Moreover, microglia secrete trypsinogen, insulin-like growth factor, and ﬁbroblast growth factor during activation to promote neurogenesis (Pérez-Martín et al., 2010; Voss et al., 2012).",
      "key": "092f9f94fc8c14d86b0d6ff076f9d0bc",
      "line": 523,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 59,
      "target": 103
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Moreover, microglia secrete trypsinogen, insulin-like growth factor, and ﬁbroblast growth factor during activation to promote neurogenesis (Pérez-Martín et al., 2010; Voss et al., 2012).",
      "key": "19ed8cf11277629ff5941cf852add6cc",
      "line": 524,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 59,
      "target": 127
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Moreover, microglia secrete trypsinogen, insulin-like growth factor, and ﬁbroblast growth factor during activation to promote neurogenesis (Pérez-Martín et al., 2010; Voss et al., 2012).",
      "key": "1f9f1c86cd2b01ed8e80067933248553",
      "line": 528,
      "relation": "increases",
      "source": 59,
      "target": 67
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Anti-inﬂammatory molecules from microglia also beneﬁt remyelination in EAE, for example, IL-4 enhances oligodendrogenesis (Butovsky et al., 2006), and activin A drives oligodendrocyte diﬀerentiation (Miron et al., 2013).",
      "key": "08583f445335af92a0144bee88674622",
      "line": 534,
      "relation": "increases",
      "source": 59,
      "target": 110
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Anti-inﬂammatory molecules from microglia also beneﬁt remyelination in EAE, for example, IL-4 enhances oligodendrogenesis (Butovsky et al., 2006), and activin A drives oligodendrocyte diﬀerentiation (Miron et al., 2013).",
      "key": "8acf97bd00a42507f030ca8f34bae469",
      "line": 536,
      "relation": "increases",
      "source": 59,
      "target": 132
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "These agents include ethyl pyruvate (Djedovi´c et al., 2017), spermidine (Yang et al., 2016), bryostatin-1(Kornbergetal.,2018),forskolin(Veremeykoetal., 2018), and lenalidomide (Weng et al., 2018).",
      "key": "b122ba325b30f5bc7d969687c142ad5d",
      "line": 815,
      "relation": "association",
      "source": 59,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "These agents include ethyl pyruvate (Djedovi´c et al., 2017), spermidine (Yang et al., 2016), bryostatin-1(Kornbergetal.,2018),forskolin(Veremeykoetal., 2018), and lenalidomide (Weng et al., 2018).",
      "key": "12043e34bce3683f8c33e7f19af7b525",
      "line": 816,
      "relation": "association",
      "source": 59,
      "target": 8
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "These agents include ethyl pyruvate (Djedovi´c et al., 2017), spermidine (Yang et al., 2016), bryostatin-1(Kornbergetal.,2018),forskolin(Veremeykoetal., 2018), and lenalidomide (Weng et al., 2018).",
      "key": "5f73f87b8c3a174f4b7f8d9097ea52f4",
      "line": 817,
      "relation": "association",
      "source": 59,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "These agents include ethyl pyruvate (Djedovi´c et al., 2017), spermidine (Yang et al., 2016), bryostatin-1(Kornbergetal.,2018),forskolin(Veremeykoetal., 2018), and lenalidomide (Weng et al., 2018).",
      "key": "424dd49c93728cece4576dd8dcd1be7d",
      "line": 818,
      "relation": "association",
      "source": 59,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "These agents include ethyl pyruvate (Djedovi´c et al., 2017), spermidine (Yang et al., 2016), bryostatin-1(Kornbergetal.,2018),forskolin(Veremeykoetal., 2018), and lenalidomide (Weng et al., 2018).",
      "key": "2b62672c45191c9436852e275d6d95de",
      "line": 819,
      "relation": "association",
      "source": 59,
      "target": 10
    },
    {
      "annotations": {
        "Cell": {
          "neuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Monocyte-derived macrophages and CNS-resident phagocytic cells can promote neuroinﬂammation, thereby inducing MS, but they can also play neuroprotective and anti-inﬂammatory roles, depending on many factors.",
      "key": "7f18945d8cdedbc289700f3aa64199db",
      "line": 99,
      "relation": "increases",
      "source": 60,
      "target": 138
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Classically activated neuroinﬂammatory microglia secrete TNF-α, and C1q, inducing A1 astrocyte dysfunction, thereby resulting in the dysfunction of both oligodendrocytes and neurons (Liddelow et al., 2017; Rothhammer et al., 2018).",
      "key": "67a53987bb6fa57a683ae96ef3532036",
      "line": 403,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 60,
      "target": 118
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Classically activated neuroinﬂammatory microglia secrete TNF-α, and C1q, inducing A1 astrocyte dysfunction, thereby resulting in the dysfunction of both oligodendrocytes and neurons (Liddelow et al., 2017; Rothhammer et al., 2018).",
      "key": "97a8c5c64392da7f6bf8b44af3f1507b",
      "line": 404,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 60,
      "target": 86
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Classically activated neuroinﬂammatory microglia secrete TNF-α, and C1q, inducing A1 astrocyte dysfunction, thereby resulting in the dysfunction of both oligodendrocytes and neurons (Liddelow et al., 2017; Rothhammer et al., 2018).",
      "key": "f53af15ea565e2742adee573e734745d",
      "line": 407,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 60,
      "target": 26
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Classically activated neuroinﬂammatory microglia secrete TNF-α, and C1q, inducing A1 astrocyte dysfunction, thereby resulting in the dysfunction of both oligodendrocytes and neurons (Liddelow et al., 2017; Rothhammer et al., 2018).",
      "key": "ca359c6bc201c799869f4cb0dd4a8e7b",
      "line": 410,
      "object": {
        "modifier": "Activity"
      },
      "relation": "negativeCorrelation",
      "source": 60,
      "target": 34
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Classically activated neuroinﬂammatory microglia secrete TNF-α, and C1q, inducing A1 astrocyte dysfunction, thereby resulting in the dysfunction of both oligodendrocytes and neurons (Liddelow et al., 2017; Rothhammer et al., 2018).",
      "key": "f2788b0301747f2347b58884f0ee560d",
      "line": 411,
      "object": {
        "modifier": "Activity"
      },
      "relation": "negativeCorrelation",
      "source": 60,
      "target": 35
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Importantly, mitochondrial disturbances have been demonstrated in modulating MS lesions,reactive oxygen species and reactive nitrogen species generated by the activated microglia also lead to intra-axonal mitochondrial injury (Balaban et al., 2005;Haileetal.,2017).",
      "key": "3ad9f58a1e00d05eb9518d6803a0fa22",
      "line": 417,
      "relation": "association",
      "source": 138,
      "target": 136
    },
    {
      "annotations": {
        "Anatomy": {
          "perivascular space": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Perivascular macrophages, typically CD163+HLADR+, are markedly increased in MS patients and EAE-aﬀected animals (Zhang et al., 2011; Mammana et al., 2018).",
      "key": "c114fcbcc1757c0d8c4ec3d7a8e15e5a",
      "line": 649,
      "relation": "increases",
      "source": 138,
      "target": 31
    },
    {
      "annotations": {
        "Anatomy": {
          "choroid plexus": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "The severity of MS coincides with enhanced levels of inﬁltrated leukocytes in the choroid plexus (Engelhardt et al., 2001; Vercellino et al., 2008; Mitchell et al., 2009), strongly indicating that inﬂammation at the choroid plexus contributes to the disease.",
      "key": "d5b5d34570fb3f591a51f73618771c2d",
      "line": 745,
      "relation": "association",
      "source": 138,
      "target": 18
    },
    {
      "annotations": {
        "Anatomy": {
          "cerebrospinal fluid": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Chemokines like CXCL9 and CXCL10 accumulate in large quantities in the CSF during MS progression (Edwards et al., 2013; Puthenparampil et al., 2017), but whether they are secreted by macrophages needs to be conﬁrmed.",
      "key": "1753b6e7a0fc4004ed23e75e12ebe649",
      "line": 753,
      "relation": "increases",
      "source": 138,
      "target": 99
    },
    {
      "annotations": {
        "Anatomy": {
          "cerebrospinal fluid": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Chemokines like CXCL9 and CXCL10 accumulate in large quantities in the CSF during MS progression (Edwards et al., 2013; Puthenparampil et al., 2017), but whether they are secreted by macrophages needs to be conﬁrmed.",
      "key": "6ac8b4486147b80052c1fe585eb13fad",
      "line": 754,
      "relation": "increases",
      "source": 138,
      "target": 97
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "The long non-coding RNA GAS5, a suppresser of microglial M2 polarization, is expressed at a high level within microglia in MS patients.",
      "key": "d5850a70cb416028c07a97f0ad7459ac",
      "line": 844,
      "object": {
        "location": {
          "name": "Microglia",
          "namespace": "MESH"
        }
      },
      "relation": "increases",
      "source": 138,
      "target": 146
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "After CNS injury and inﬂammation, while microglia situated in the parenchyma and macrophages in the choroid plexus, perivascular space, and the meninges are activated, monocytes from the blood cross the damaged BBB and become monocyte derived macrophages in the CNS (Lassmann et al., 2001).",
      "key": "c36ae9c684fa6b9bcb2d4bd6933fa471",
      "line": 348,
      "object": {
        "location": {
          "name": "C74601",
          "namespace": "NCIT"
        },
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 144,
      "target": 32
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "After CNS injury and inﬂammation, while microglia situated in the parenchyma and macrophages in the choroid plexus, perivascular space, and the meninges are activated, monocytes from the blood cross the damaged BBB and become monocyte derived macrophages in the CNS (Lassmann et al., 2001).",
      "key": "53bf47ae6f5554b0ed24865e4af51b0c",
      "line": 349,
      "object": {
        "location": {
          "name": "Choroid Plexus",
          "namespace": "MESH"
        },
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 144,
      "target": 31
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "After CNS injury and inﬂammation, while microglia situated in the parenchyma and macrophages in the choroid plexus, perivascular space, and the meninges are activated, monocytes from the blood cross the damaged BBB and become monocyte derived macrophages in the CNS (Lassmann et al., 2001).",
      "key": "1d21311ff0f34d39eeb8809e3e0db18e",
      "line": 350,
      "object": {
        "location": {
          "name": "C83196",
          "namespace": "NCIT"
        },
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 144,
      "target": 31
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "After CNS injury and inﬂammation, while microglia situated in the parenchyma and macrophages in the choroid plexus, perivascular space, and the meninges are activated, monocytes from the blood cross the damaged BBB and become monocyte derived macrophages in the CNS (Lassmann et al., 2001).",
      "key": "78e01f67abc99ecde37361b740a1c08f",
      "line": 351,
      "object": {
        "location": {
          "name": "Meninges",
          "namespace": "MESH"
        },
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 144,
      "target": 31
    },
    {
      "annotations": {
        "Anatomy": {
          "brain white matter": true
        },
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Pronounced microglial activation with high expression levels of pro-inﬂammatory genes can be found in lesion areas and normal-appearing white matter of MS patients(Lucchinettietal., 2000; Singh et al., 2013; Zrzavy et al., 2017).",
      "key": "01879fa60033211e67a0471b9636e939",
      "line": 360,
      "relation": "increases",
      "source": 144,
      "target": 59
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "In contrast to microglia, macrophages express TREM-1 rather than TREM-2,and although this isoform plays a role in inﬂammatory responses (Colonna and Facchetti,2003),the functions of TREM1 still need to be further studied in a CNS autoimmunity context.",
      "key": "9993458df6166de3ba6bf67aaeb53a3a",
      "line": 631,
      "relation": "association",
      "source": 144,
      "target": 122
    },
    {
      "annotations": {
        "Cell": {
          "leptomeningeal cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Leptomeningeal macrophages increase the expression of transforming growth factor-β in glial cells and cortical neurons by releasing prostaglandin E2 during inﬂammation (Wu et al., 2007).",
      "key": "94d787b4ef029c3dd45f80541abde574",
      "line": 728,
      "relation": "increases",
      "source": 144,
      "target": 58
    },
    {
      "annotations": {
        "Anatomy": {
          "choroid plexus": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "The severity of MS coincides with enhanced levels of inﬁltrated leukocytes in the choroid plexus (Engelhardt et al., 2001; Vercellino et al., 2008; Mitchell et al., 2009), strongly indicating that inﬂammation at the choroid plexus contributes to the disease.",
      "key": "63fd963e1d34b1746c3ca43ccec28681",
      "line": 746,
      "relation": "increases",
      "source": 144,
      "target": 138
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Cell": {
          "neuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Monocyte-derived macrophages and CNS-resident phagocytic cells can promote neuroinﬂammation, thereby inducing MS, but they can also play neuroprotective and anti-inﬂammatory roles, depending on many factors.",
      "key": "aad9bc2c1873d50eeafca511f2ae3798",
      "line": 106,
      "relation": "increases",
      "source": 38,
      "target": 60
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Cell": {
          "neuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Monocyte-derived macrophages and CNS-resident phagocytic cells can promote neuroinﬂammation, thereby inducing MS, but they can also play neuroprotective and anti-inﬂammatory roles, depending on many factors.",
      "key": "25cf790b3f64e0cacc9fec0576e841be",
      "line": 108,
      "relation": "increases",
      "source": 38,
      "target": 138
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Monocyte-derived macrophages and CNS-resident phagocytic cells can promote neuroinﬂammation, thereby inducing MS, but they can also play neuroprotective and anti-inﬂammatory roles, depending on many factors.",
      "key": "1b30deb328141005466bf90085f0b533",
      "line": 110,
      "relation": "increases",
      "source": 38,
      "target": 77
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Monocyte-derived macrophages and CNS-resident phagocytic cells can promote neuroinﬂammation, thereby inducing MS, but they can also play neuroprotective and anti-inﬂammatory roles, depending on many factors.",
      "key": "f105ef8d92cfe16bde11753e296be256",
      "line": 111,
      "relation": "decreases",
      "source": 38,
      "target": 144
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Studies have demonstrated that microglia mediate synaptic pruning and trophic-factor production through fractalkine-CX3CR1 signaling in neurodevelopment (Tremblay et al., 2010; Ransohoﬀ and El Khoury, 2014; Schafer and Stevens, 2015; Miyamoto et al., 2016)",
      "key": "0924e0f1e66bcef9c445855ae8be6227",
      "line": 118,
      "relation": "increases",
      "source": 81,
      "target": 72
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Studies have demonstrated that microglia mediate synaptic pruning and trophic-factor production through fractalkine-CX3CR1 signaling in neurodevelopment (Tremblay et al., 2010; Ransohoﬀ and El Khoury, 2014; Schafer and Stevens, 2015; Miyamoto et al., 2016)",
      "key": "f9138a7db9fbf418bed5ff0b04b838c0",
      "line": 119,
      "relation": "increases",
      "source": 81,
      "target": 55
    },
    {
      "key": "0c3a4616f531ce8fce2e0442feeb2510",
      "relation": "partOf",
      "source": 95,
      "target": 81
    },
    {
      "key": "c1f6de5f8ff526421a3c78932eabc47b",
      "relation": "partOf",
      "source": 96,
      "target": 81
    },
    {
      "annotations": {
        "Anatomy": {
          "cerebral cortex": true
        },
        "Cell": {
          "neuron": true
        },
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Fractalkine receptor deﬁcient mice showed decreased neuron survival in layer V cortical neurons during the ﬁrst postnatal week because of the reduced secretion of insulin-like growth factor from microglia (Ueno et al., 2013).",
      "key": "7f83cb6143f3ba8f8e44eeb6c9849998",
      "line": 130,
      "relation": "increases",
      "source": 96,
      "target": 70
    },
    {
      "annotations": {
        "Anatomy": {
          "cerebral cortex": true
        },
        "Cell": {
          "neuron": true
        },
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Fractalkine receptor deﬁcient mice showed decreased neuron survival in layer V cortical neurons during the ﬁrst postnatal week because of the reduced secretion of insulin-like growth factor from microglia (Ueno et al., 2013).",
      "key": "c923e15655646eed9f5147d266e58603",
      "line": 132,
      "relation": "increases",
      "source": 103,
      "target": 70
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Moreover, microglia secrete trypsinogen, insulin-like growth factor, and ﬁbroblast growth factor during activation to promote neurogenesis (Pérez-Martín et al., 2010; Voss et al., 2012).",
      "key": "8942e7926715c568dd008a4a0d3844ed",
      "line": 526,
      "relation": "increases",
      "source": 103,
      "target": 67
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Furthermore, microglia depletion by the Cre-Lox technique led to deﬁciencies in multiple learning tasks, as well as a signiﬁcant reduction in learning related synapse formation (Parkhurst et al., 2014).",
      "key": "561389085a2bb52defb3d049d4b7d1af",
      "line": 142,
      "relation": "increases",
      "source": 13,
      "target": 57
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "In addition, microglial-secreted BDNF could increase the activity of neuronal tropomyosin-related kinase receptor B, an important modulator in synaptic plasticity,prompting a crucial role of BDNF signaling in learning and memory-related synapse formation (Parkhurst etal.,2014).",
      "key": "9e32751255312ab0e66d22cc04afcbaa",
      "line": 152,
      "relation": "increases",
      "source": 13,
      "target": 57
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "In addition, microglial-secreted BDNF could increase the activity of neuronal tropomyosin-related kinase receptor B, an important modulator in synaptic plasticity,prompting a crucial role of BDNF signaling in learning and memory-related synapse formation (Parkhurst etal.,2014).",
      "key": "91a2e9ddeb13861c809d9a55b2423afb",
      "line": 148,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 85,
      "target": 114
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "In addition, microglial-secreted BDNF could increase the activity of neuronal tropomyosin-related kinase receptor B, an important modulator in synaptic plasticity,prompting a crucial role of BDNF signaling in learning and memory-related synapse formation (Parkhurst etal.,2014).",
      "key": "3e63f85804133cc865b084adef628aca",
      "line": 151,
      "relation": "increases",
      "source": 85,
      "target": 13
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "In addition, microglial-secreted BDNF could increase the activity of neuronal tropomyosin-related kinase receptor B, an important modulator in synaptic plasticity,prompting a crucial role of BDNF signaling in learning and memory-related synapse formation (Parkhurst etal.,2014).",
      "key": "ce352bdd846ced316971d0c96862126e",
      "line": 153,
      "relation": "increases",
      "source": 85,
      "target": 57
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "In addition, microglial-secreted BDNF could increase the activity of neuronal tropomyosin-related kinase receptor B, an important modulator in synaptic plasticity,prompting a crucial role of BDNF signaling in learning and memory-related synapse formation (Parkhurst etal.,2014).",
      "key": "cac74988d1e2a64d2981cdbc4993da74",
      "line": 149,
      "relation": "regulates",
      "source": 114,
      "target": 72
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Microglia may communicate with neurons;changes in the physiological environment such as chronic stress and light deprivation can cause hyper-ramiﬁcation of microglia and more frequent neuron–microglia contacts (Torres-Platas et al., 2014; Welberg, 2014; Yirmiya et al., 2015).",
      "key": "67c74a4874f1361c8947187b6d46eec0",
      "line": 158,
      "relation": "increases",
      "source": 48,
      "target": 59
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Microglia may communicate with neurons;changes in the physiological environment such as chronic stress and light deprivation can cause hyper-ramiﬁcation of microglia and more frequent neuron–microglia contacts (Torres-Platas et al., 2014; Welberg, 2014; Yirmiya et al., 2015).",
      "key": "235ba08908042b960e74797fd0dd7968",
      "line": 161,
      "relation": "increases",
      "source": 48,
      "target": 82
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Microglia may communicate with neurons;changes in the physiological environment such as chronic stress and light deprivation can cause hyper-ramiﬁcation of microglia and more frequent neuron–microglia contacts (Torres-Platas et al., 2014; Welberg, 2014; Yirmiya et al., 2015).",
      "key": "d3a44d8ff1d6eb12923a61e593ed2512",
      "line": 159,
      "relation": "decreases",
      "source": 145,
      "target": 59
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Microglia may communicate with neurons;changes in the physiological environment such as chronic stress and light deprivation can cause hyper-ramiﬁcation of microglia and more frequent neuron–microglia contacts (Torres-Platas et al., 2014; Welberg, 2014; Yirmiya et al., 2015).",
      "key": "a719e08e31491a58b522dc5c50ae3a0f",
      "line": 162,
      "relation": "decreases",
      "source": 145,
      "target": 82
    },
    {
      "key": "ae2be5c98636c64bcdb4385ab3bcd3c3",
      "relation": "partOf",
      "source": 34,
      "target": 82
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Classically activated neuroinﬂammatory microglia secrete TNF-α, and C1q, inducing A1 astrocyte dysfunction, thereby resulting in the dysfunction of both oligodendrocytes and neurons (Liddelow et al., 2017; Rothhammer et al., 2018).",
      "key": "a36f12a62e2df2df46c9be75844e155a",
      "line": 408,
      "relation": "positiveCorrelation",
      "source": 34,
      "subject": {
        "modifier": "Activity"
      },
      "target": 26
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Classically activated neuroinﬂammatory microglia secrete TNF-α, and C1q, inducing A1 astrocyte dysfunction, thereby resulting in the dysfunction of both oligodendrocytes and neurons (Liddelow et al., 2017; Rothhammer et al., 2018).",
      "key": "823566c88979386e53c31dc7af9a1e87",
      "line": 410,
      "relation": "negativeCorrelation",
      "source": 34,
      "subject": {
        "modifier": "Activity"
      },
      "target": 60
    },
    {
      "key": "528d9e1aac5db24e4d1245ab73b6180d",
      "relation": "hasVariant",
      "source": 133,
      "target": 134
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Once “danger” signals are detected in the surrounding environment, microglia rapidly change into a reactive phenotype, characterized by larger soma, and release various complement factors to facilitate neuron and tissue repair (Hanisch and Kettenmann, 2007; Graeber and Streit, 2010; Kettenmannetal.,2011).",
      "key": "a81ef90e8d8d48e3f73d5de481bb8134",
      "line": 177,
      "relation": "increases",
      "source": 40,
      "target": 59
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Upon detecting “danger” signals, both microglia and non-parenchymal macrophages produce large amounts of chemokines and cytokines to promote leukocyte inﬁltration into the CNS parenchyma and function as APCs to reactivate T cells in the CNS (Gallietal.,2011;Krausgruber et al.,2011).",
      "key": "b91931fc16ca36aa8af8c75e4ea52970",
      "line": 327,
      "relation": "increases",
      "source": 40,
      "target": 59
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Upon detecting “danger” signals, both microglia and non-parenchymal macrophages produce large amounts of chemokines and cytokines to promote leukocyte inﬁltration into the CNS parenchyma and function as APCs to reactivate T cells in the CNS (Gallietal.,2011;Krausgruber et al.,2011).",
      "key": "46eb641dec81df183cdde8e6e575fb29",
      "line": 328,
      "relation": "increases",
      "source": 40,
      "target": 58
    },
    {
      "annotations": {
        "Anatomy": {
          "tissue": true
        },
        "Cell": {
          "neuron": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Once “danger” signals are detected in the surrounding environment, microglia rapidly change into a reactive phenotype, characterized by larger soma, and release various complement factors to facilitate neuron and tissue repair (Hanisch and Kettenmann, 2007; Graeber and Streit, 2010; Kettenmannetal.,2011).",
      "key": "bddaf7c282e932ca12cd1b4ca8c15620",
      "line": 181,
      "relation": "increases",
      "source": 51,
      "target": 79
    },
    {
      "annotations": {
        "Anatomy": {
          "brain": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Blood Vessels": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Perivascular macrophages are critical in BBB establishment (Mendes-Jorge et al., 2009; He et al., 2016), and blockage of colony stimulating factor 1 receptor signaling leads to a decreased coverage of pericytes in brain vessels (Yamamotoetal.,2017).",
      "key": "ab57bf63d52aa1a71fc0676cb8865779",
      "line": 193,
      "relation": "increases",
      "source": 94,
      "target": 37
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Upon detecting “danger” signals, both microglia and non-parenchymal macrophages produce large amounts of chemokines and cytokines to promote leukocyte inﬁltration into the CNS parenchyma and function as APCs to reactivate T cells in the CNS (Gallietal.,2011;Krausgruber et al.,2011).",
      "key": "878fe8f0c288b83e16c9e227242ef44c",
      "line": 336,
      "relation": "isA",
      "source": 18,
      "subject": {
        "location": {
          "name": "C74601",
          "namespace": "NCIT"
        }
      },
      "target": 14
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Upon detecting “danger” signals, both microglia and non-parenchymal macrophages produce large amounts of chemokines and cytokines to promote leukocyte inﬁltration into the CNS parenchyma and function as APCs to reactivate T cells in the CNS (Gallietal.,2011;Krausgruber et al.,2011).",
      "key": "84d159ce124cf4bd0afb0883814ecd8e",
      "line": 337,
      "relation": "increases",
      "source": 18,
      "subject": {
        "location": {
          "name": "C74601",
          "namespace": "NCIT"
        }
      },
      "target": 44
    },
    {
      "annotations": {
        "Anatomy": {
          "choroid plexus": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "The severity of MS coincides with enhanced levels of inﬁltrated leukocytes in the choroid plexus (Engelhardt et al., 2001; Vercellino et al., 2008; Mitchell et al., 2009), strongly indicating that inﬂammation at the choroid plexus contributes to the disease.",
      "key": "42ca95dd13786ebc19fb413a427bbd85",
      "line": 745,
      "relation": "association",
      "source": 18,
      "target": 138
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "M1 macrophages and microglia are potent APCs, causing an adaptive immune response to clear foreign substances and abnormal proteins (Das et al., 2015).",
      "key": "a350d8b377c9a0c5b89cb2e3753e0f46",
      "line": 273,
      "relation": "increases",
      "source": 14,
      "target": 69
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Interferon-gamma and lipopolysaccharide treatment can generate M1 cells, while IL-4, IL-10, or IL-13 are activators of M2 cells.",
      "key": "93b57ab8e6ad261d80ab3f202214f7a9",
      "line": 236,
      "relation": "increases",
      "source": 102,
      "target": 43
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "M1 macrophages and microglia are characterized by an amoeboid shape, and they release pro-inﬂammatory cytokines, such as IL-6, IFN-γ, IL-23, TNF-α; inducible nitric oxide synthase; chemokines, including CCL 4, CCL5, and CCL8; and CXCL 2, CXCL4, and CXCL9 (Juhas et al., 2015; Kapellos and Iqbal, 2016).",
      "key": "040c78d8f7e461b98bd1cb6ae1da283f",
      "line": 245,
      "relation": "increases",
      "source": 43,
      "target": 111
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "M1 macrophages and microglia are characterized by an amoeboid shape, and they release pro-inﬂammatory cytokines, such as IL-6, IFN-γ, IL-23, TNF-α; inducible nitric oxide synthase; chemokines, including CCL 4, CCL5, and CCL8; and CXCL 2, CXCL4, and CXCL9 (Juhas et al., 2015; Kapellos and Iqbal, 2016).",
      "key": "c22f5946acdd11afe09ba93ebaef9521",
      "line": 246,
      "relation": "increases",
      "source": 43,
      "target": 102
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "M1 macrophages and microglia are characterized by an amoeboid shape, and they release pro-inﬂammatory cytokines, such as IL-6, IFN-γ, IL-23, TNF-α; inducible nitric oxide synthase; chemokines, including CCL 4, CCL5, and CCL8; and CXCL 2, CXCL4, and CXCL9 (Juhas et al., 2015; Kapellos and Iqbal, 2016).",
      "key": "f03a99d50aeb7ffba0ca955fbf70700c",
      "line": 247,
      "relation": "increases",
      "source": 43,
      "target": 129
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "M1 macrophages and microglia are characterized by an amoeboid shape, and they release pro-inﬂammatory cytokines, such as IL-6, IFN-γ, IL-23, TNF-α; inducible nitric oxide synthase; chemokines, including CCL 4, CCL5, and CCL8; and CXCL 2, CXCL4, and CXCL9 (Juhas et al., 2015; Kapellos and Iqbal, 2016).",
      "key": "f4caa490d7468a8531df4d4362ab8db2",
      "line": 248,
      "relation": "increases",
      "source": 43,
      "target": 118
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "M1 macrophages and microglia are characterized by an amoeboid shape, and they release pro-inﬂammatory cytokines, such as IL-6, IFN-γ, IL-23, TNF-α; inducible nitric oxide synthase; chemokines, including CCL 4, CCL5, and CCL8; and CXCL 2, CXCL4, and CXCL9 (Juhas et al., 2015; Kapellos and Iqbal, 2016).",
      "key": "968de1123077722403935c926bb41140",
      "line": 249,
      "relation": "increases",
      "source": 43,
      "target": 112
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "M1 macrophages and microglia are characterized by an amoeboid shape, and they release pro-inﬂammatory cytokines, such as IL-6, IFN-γ, IL-23, TNF-α; inducible nitric oxide synthase; chemokines, including CCL 4, CCL5, and CCL8; and CXCL 2, CXCL4, and CXCL9 (Juhas et al., 2015; Kapellos and Iqbal, 2016).",
      "key": "d0ad374ee1918775f51070559bcda17b",
      "line": 250,
      "relation": "increases",
      "source": 43,
      "target": 89
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "M1 macrophages and microglia are characterized by an amoeboid shape, and they release pro-inﬂammatory cytokines, such as IL-6, IFN-γ, IL-23, TNF-α; inducible nitric oxide synthase; chemokines, including CCL 4, CCL5, and CCL8; and CXCL 2, CXCL4, and CXCL9 (Juhas et al., 2015; Kapellos and Iqbal, 2016).",
      "key": "690dbb34274889474836feb9472f6f77",
      "line": 251,
      "relation": "increases",
      "source": 43,
      "target": 90
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "M1 macrophages and microglia are characterized by an amoeboid shape, and they release pro-inﬂammatory cytokines, such as IL-6, IFN-γ, IL-23, TNF-α; inducible nitric oxide synthase; chemokines, including CCL 4, CCL5, and CCL8; and CXCL 2, CXCL4, and CXCL9 (Juhas et al., 2015; Kapellos and Iqbal, 2016).",
      "key": "09befc84d7ae856768c8ddd82b64ef99",
      "line": 252,
      "relation": "increases",
      "source": 43,
      "target": 91
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "M1 macrophages and microglia are characterized by an amoeboid shape, and they release pro-inﬂammatory cytokines, such as IL-6, IFN-γ, IL-23, TNF-α; inducible nitric oxide synthase; chemokines, including CCL 4, CCL5, and CCL8; and CXCL 2, CXCL4, and CXCL9 (Juhas et al., 2015; Kapellos and Iqbal, 2016).",
      "key": "ce6589692104137889d11bb439737d65",
      "line": 253,
      "relation": "increases",
      "source": 43,
      "target": 98
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "M1 macrophages and microglia are characterized by an amoeboid shape, and they release pro-inﬂammatory cytokines, such as IL-6, IFN-γ, IL-23, TNF-α; inducible nitric oxide synthase; chemokines, including CCL 4, CCL5, and CCL8; and CXCL 2, CXCL4, and CXCL9 (Juhas et al., 2015; Kapellos and Iqbal, 2016).",
      "key": "1122eb847ffd5c75e1e69b3b8cf065b1",
      "line": 254,
      "relation": "increases",
      "source": 43,
      "target": 115
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "M1 macrophages and microglia are characterized by an amoeboid shape, and they release pro-inﬂammatory cytokines, such as IL-6, IFN-γ, IL-23, TNF-α; inducible nitric oxide synthase; chemokines, including CCL 4, CCL5, and CCL8; and CXCL 2, CXCL4, and CXCL9 (Juhas et al., 2015; Kapellos and Iqbal, 2016).",
      "key": "fc7d0f1500a7a175033e29a9bb76e03f",
      "line": 255,
      "relation": "increases",
      "source": 43,
      "target": 99
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "M1 macrophages and microglia are potent APCs, causing an adaptive immune response to clear foreign substances and abnormal proteins (Das et al., 2015).",
      "key": "e33467e988f9ad14ab496c9a795fe4a2",
      "line": 271,
      "relation": "isA",
      "source": 43,
      "target": 14
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "M1 macrophages and microglia are potent APCs, causing an adaptive immune response to clear foreign substances and abnormal proteins (Das et al., 2015).",
      "key": "5dca26b05abdb12580690c54cf95540a",
      "line": 274,
      "relation": "increases",
      "source": 43,
      "target": 69
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "M1 macrophages and microglia are potent APCs, causing an adaptive immune response to clear foreign substances and abnormal proteins (Das et al., 2015).",
      "key": "ddcfac210c1489fbd69f4b0dc7d37505",
      "line": 277,
      "relation": "decreases",
      "source": 43,
      "target": 134
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Interferon-gamma and lipopolysaccharide treatment can generate M1 cells, while IL-4, IL-10, or IL-13 are activators of M2 cells.",
      "key": "6cb8e3709744296e53ab6e8a36fc600c",
      "line": 237,
      "relation": "increases",
      "source": 30,
      "target": 43
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Interferon-gamma and lipopolysaccharide treatment can generate M1 cells, while IL-4, IL-10, or IL-13 are activators of M2 cells.",
      "key": "ba88471b87490fc55efd9adbcb862cad",
      "line": 238,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 110,
      "target": 42
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "In contrast, M2 macrophages and microglia have smaller cell bodies and a branched structure(RansohoﬀandPerry,2009),and they express a variety of anti-inﬂammatory molecules, including IL-4, IL-10, IL-13, and transforming growth factor-β (David and Kroner, 2011).",
      "key": "09429c1416d6f73f42c82769776f70f8",
      "line": 291,
      "relation": "decreases",
      "source": 110,
      "target": 56
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Anti-inﬂammatory molecules from microglia also beneﬁt remyelination in EAE, for example, IL-4 enhances oligodendrogenesis (Butovsky et al., 2006), and activin A drives oligodendrocyte diﬀerentiation (Miron et al., 2013).",
      "key": "91a41698866769e14a754d3cd22fa634",
      "line": 538,
      "relation": "decreases",
      "source": 110,
      "target": 56
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Anti-inﬂammatory molecules from microglia also beneﬁt remyelination in EAE, for example, IL-4 enhances oligodendrogenesis (Butovsky et al., 2006), and activin A drives oligodendrocyte diﬀerentiation (Miron et al., 2013).",
      "key": "ea17143550798ef139c6299fc700a0c2",
      "line": 535,
      "relation": "increases",
      "source": 110,
      "target": 61
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Anti-inﬂammatory molecules from microglia also beneﬁt remyelination in EAE, for example, IL-4 enhances oligodendrogenesis (Butovsky et al., 2006), and activin A drives oligodendrocyte diﬀerentiation (Miron et al., 2013).",
      "key": "1f7c2f73ed5585477180416ce5cd2215",
      "line": 540,
      "relation": "increases",
      "source": 110,
      "target": 78
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "In contrast, M2 macrophages and microglia have smaller cell bodies and a branched structure(RansohoﬀandPerry,2009),and they express a variety of anti-inﬂammatory molecules, including IL-4, IL-10, IL-13, and transforming growth factor-β (David and Kroner, 2011).",
      "key": "a2dfdb60d8320e49ef7b323ebbe1f805",
      "line": 283,
      "relation": "increases",
      "source": 42,
      "target": 110
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "In contrast, M2 macrophages and microglia have smaller cell bodies and a branched structure(RansohoﬀandPerry,2009),and they express a variety of anti-inﬂammatory molecules, including IL-4, IL-10, IL-13, and transforming growth factor-β (David and Kroner, 2011).",
      "key": "e7242fce12cf0b4087e8698d2262f6e7",
      "line": 284,
      "relation": "increases",
      "source": 42,
      "target": 104
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "In contrast, M2 macrophages and microglia have smaller cell bodies and a branched structure(RansohoﬀandPerry,2009),and they express a variety of anti-inﬂammatory molecules, including IL-4, IL-10, IL-13, and transforming growth factor-β (David and Kroner, 2011).",
      "key": "bfc1b96a1d383432f0808f032eb6dad3",
      "line": 285,
      "relation": "increases",
      "source": 42,
      "target": 106
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "In contrast, M2 macrophages and microglia have smaller cell bodies and a branched structure(RansohoﬀandPerry,2009),and they express a variety of anti-inﬂammatory molecules, including IL-4, IL-10, IL-13, and transforming growth factor-β (David and Kroner, 2011).",
      "key": "acc31679b044e82096a49b55300d8f61",
      "line": 286,
      "relation": "increases",
      "source": 42,
      "target": 117
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "These contribute to immunoregulation by inhibiting inﬂammation, remodeling tissue, promoting angiogenesis, and clearing parasites (Banerjee et al., 2013).",
      "key": "a15a705d0ca126bba9c6a6ec192aedb3",
      "line": 299,
      "relation": "regulates",
      "source": 42,
      "target": 76
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "These contribute to immunoregulation by inhibiting inﬂammation, remodeling tissue, promoting angiogenesis, and clearing parasites (Banerjee et al., 2013).",
      "key": "33d93a0b82c69e28765fb65597c4acfa",
      "line": 300,
      "relation": "decreases",
      "source": 42,
      "target": 144
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "These contribute to immunoregulation by inhibiting inﬂammation, remodeling tissue, promoting angiogenesis, and clearing parasites (Banerjee et al., 2013).",
      "key": "c2a50528368399385f44c0136355812b",
      "line": 301,
      "relation": "increases",
      "source": 42,
      "target": 64
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "These contribute to immunoregulation by inhibiting inﬂammation, remodeling tissue, promoting angiogenesis, and clearing parasites (Banerjee et al., 2013).",
      "key": "8c278cf4fc2a617a9e2323821d16c735",
      "line": 302,
      "relation": "increases",
      "source": 42,
      "target": 65
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "These contribute to immunoregulation by inhibiting inﬂammation, remodeling tissue, promoting angiogenesis, and clearing parasites (Banerjee et al., 2013).",
      "key": "83a4dd1fcda9c5b9b44482aca2bd6b1d",
      "line": 303,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 42,
      "target": 36
    },
    {
      "annotations": {
        "Anatomy": {
          "perivascular space": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Moreover, M2 perivascular macrophages can promote the diﬀerentiation of Th2 and Treg cells due to their anti-inﬂammatory characteristic (Weberetal.,2007).",
      "key": "d988038ae58526c4c7a866937d623ab8",
      "line": 700,
      "relation": "association",
      "source": 42,
      "target": 24
    },
    {
      "annotations": {
        "Anatomy": {
          "perivascular space": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Moreover, M2 perivascular macrophages can promote the diﬀerentiation of Th2 and Treg cells due to their anti-inﬂammatory characteristic (Weberetal.,2007).",
      "key": "c98929644e814f5c61b7004252ddc3a8",
      "line": 701,
      "relation": "increases",
      "source": 42,
      "target": 63
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "However, remote brain choroid plexus can also recruit M2-like macrophages to an injured spinal cord, which might beneﬁt myelin repair(Shechteretal.,2013).",
      "key": "ff8284b38c61d712070c48cd4d95fb80",
      "line": 761,
      "relation": "increases",
      "source": 42,
      "subject": {
        "location": {
          "name": "Spinal Cord",
          "namespace": "MESH"
        }
      },
      "target": 78
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Interferon-gamma and lipopolysaccharide treatment can generate M1 cells, while IL-4, IL-10, or IL-13 are activators of M2 cells.",
      "key": "4874712c614b0bdbc91f757254d4506c",
      "line": 239,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 104,
      "target": 42
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "In contrast, M2 macrophages and microglia have smaller cell bodies and a branched structure(RansohoﬀandPerry,2009),and they express a variety of anti-inﬂammatory molecules, including IL-4, IL-10, IL-13, and transforming growth factor-β (David and Kroner, 2011).",
      "key": "a9d4e4ede1aa80a253811ea38710a6e5",
      "line": 292,
      "relation": "decreases",
      "source": 104,
      "target": 56
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Interferon-gamma and lipopolysaccharide treatment can generate M1 cells, while IL-4, IL-10, or IL-13 are activators of M2 cells.",
      "key": "b7ff36b300ccad84f7dec89ffe243187",
      "line": 240,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 106,
      "target": 42
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "In contrast, M2 macrophages and microglia have smaller cell bodies and a branched structure(RansohoﬀandPerry,2009),and they express a variety of anti-inﬂammatory molecules, including IL-4, IL-10, IL-13, and transforming growth factor-β (David and Kroner, 2011).",
      "key": "b991a414edd2814908b16bb4fe9809c9",
      "line": 293,
      "relation": "decreases",
      "source": 106,
      "target": 56
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Microglia also secrete a series of pro-inﬂammatory cytokines such as IL-18, IL-6, and IL-1b and chemokines like CCL2 and CCL5 to aggravate both MS and EAE (Merson et al., 2010; Jiang et al., 2014).",
      "key": "919ef28ffd61cc83f0e9c3c90cecfa5f",
      "line": 459,
      "relation": "increases",
      "source": 111,
      "target": 56
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Microglia also secrete a series of pro-inﬂammatory cytokines such as IL-18, IL-6, and IL-1b and chemokines like CCL2 and CCL5 to aggravate both MS and EAE (Merson et al., 2010; Jiang et al., 2014).",
      "key": "4df7541a9988de0175d01f7042146056",
      "line": 464,
      "relation": "increases",
      "source": 111,
      "target": 140
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "IL-6 has also been demonstrated to be critical for CNS autoimmunity, as IL6-deﬁcient mice demonstrated alleviated EAE (Samoilova et al., 1998).",
      "key": "bf330d8f4bb83b2e9fad9277f79fce04",
      "line": 606,
      "relation": "decreases",
      "source": 111,
      "target": 140
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Microglia also secrete a series of pro-inﬂammatory cytokines such as IL-18, IL-6, and IL-1b and chemokines like CCL2 and CCL5 to aggravate both MS and EAE (Merson et al., 2010; Jiang et al., 2014).",
      "key": "0a517c9ffa7241af4ccfbabb6906f71b",
      "line": 469,
      "relation": "increases",
      "source": 111,
      "target": 138
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Macrophages also secrete large amounts of pro-inﬂammatory cytokines, such as IL6, IL-12, TNF-α, IL-1, and IL-23, to aggravate the inﬂammatory response (Valentin-Torres et al., 2016).",
      "key": "0324ac7bf6e1492922d5df9f493daddb",
      "line": 592,
      "relation": "increases",
      "source": 111,
      "target": 144
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "IL-6 has also been demonstrated to be critical for CNS autoimmunity, as IL6-deﬁcient mice demonstrated alleviated EAE (Samoilova et al., 1998).",
      "key": "fef1cf7b595f34d8d68cdd1e65eb631b",
      "line": 604,
      "relation": "positiveCorrelation",
      "source": 111,
      "target": 142
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Macrophages also secrete large amounts of pro-inﬂammatory cytokines, such as IL6, IL-12, TNF-α, IL-1, and IL-23, to aggravate the inﬂammatory response (Valentin-Torres et al., 2016).",
      "key": "0d30c61b3f3f587dc463834207f3dd4c",
      "line": 588,
      "relation": "increases",
      "source": 129,
      "target": 144
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Activated microglia in EAE mice may produce large amounts of TNFα and thus induce excessive glutamate, leading to spontaneous and miniature excitatory post-synaptic currents (Centonze et al., 2009, 2010).",
      "key": "8a0390761641c420236bedeae8a0e688",
      "line": 387,
      "relation": "increases",
      "source": 118,
      "target": 0
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Classically activated neuroinﬂammatory microglia secrete TNF-α, and C1q, inducing A1 astrocyte dysfunction, thereby resulting in the dysfunction of both oligodendrocytes and neurons (Liddelow et al., 2017; Rothhammer et al., 2018).",
      "key": "e0a4454e2e37bf7d1dafdad87e1177a7",
      "line": 405,
      "object": {
        "modifier": "Activity"
      },
      "relation": "negativeCorrelation",
      "source": 118,
      "target": 26
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Interestingly, pro-inﬂammatory cytokine TNF has neuroprotective functions in EAE(Wolfetal.,2017),and deletion of microglial TNFR2 causing early disease onset, with increased leukocyte inﬁltration,demyelination and T cell activation in CNS (Gao et al., 2017).",
      "key": "303f6c505a1c45218fbe4e70c4b966e7",
      "line": 547,
      "relation": "increases",
      "source": 118,
      "target": 77
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Macrophages also secrete large amounts of pro-inﬂammatory cytokines, such as IL6, IL-12, TNF-α, IL-1, and IL-23, to aggravate the inﬂammatory response (Valentin-Torres et al., 2016).",
      "key": "b8399d93eaa66974ce6100c530ea3d86",
      "line": 590,
      "relation": "increases",
      "source": 118,
      "target": 144
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Microglia also secrete a series of pro-inﬂammatory cytokines such as IL-18, IL-6, and IL-1b and chemokines like CCL2 and CCL5 to aggravate both MS and EAE (Merson et al., 2010; Jiang et al., 2014).",
      "key": "c92b84cad82140f1a1a2c0fda6873308",
      "line": 462,
      "relation": "increases",
      "source": 90,
      "target": 56
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Microglia also secrete a series of pro-inﬂammatory cytokines such as IL-18, IL-6, and IL-1b and chemokines like CCL2 and CCL5 to aggravate both MS and EAE (Merson et al., 2010; Jiang et al., 2014).",
      "key": "264b1794aab1955e7c0b11c72d132196",
      "line": 467,
      "relation": "increases",
      "source": 90,
      "target": 140
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Microglia also secrete a series of pro-inﬂammatory cytokines such as IL-18, IL-6, and IL-1b and chemokines like CCL2 and CCL5 to aggravate both MS and EAE (Merson et al., 2010; Jiang et al., 2014).",
      "key": "c3f6fae714c8e3e532e81c62c942cf26",
      "line": 472,
      "relation": "increases",
      "source": 90,
      "target": 138
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Bone marrow chimeric mice show that TRPM2 expressed by CNS-inﬁltrating macrophages prompts the production of CXCL2, thus increasing neutrophil inﬁltration and contributing to the progression of EAE (Tsutsui et al., 2018).",
      "key": "e7cae2e14f2826ef03be3b5cee30f4c0",
      "line": 575,
      "relation": "increases",
      "source": 98,
      "target": 73
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Bone marrow chimeric mice show that TRPM2 expressed by CNS-inﬁltrating macrophages prompts the production of CXCL2, thus increasing neutrophil inﬁltration and contributing to the progression of EAE (Tsutsui et al., 2018).",
      "key": "04b232f43339bf14012d4437e26955d7",
      "line": 576,
      "relation": "increases",
      "source": 98,
      "target": 140
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "M1 macrophages and microglia are potent APCs, causing an adaptive immune response to clear foreign substances and abnormal proteins (Das et al., 2015).",
      "key": "d7752521e16211c9e2bb758663729269",
      "line": 276,
      "relation": "decreases",
      "source": 69,
      "target": 134
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "In contrast, M2 macrophages and microglia have smaller cell bodies and a branched structure(RansohoﬀandPerry,2009),and they express a variety of anti-inﬂammatory molecules, including IL-4, IL-10, IL-13, and transforming growth factor-β (David and Kroner, 2011).",
      "key": "344233b524921c55c61c3bfef354f367",
      "line": 294,
      "relation": "decreases",
      "source": 117,
      "target": 56
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Upon detecting “danger” signals, both microglia and non-parenchymal macrophages produce large amounts of chemokines and cytokines to promote leukocyte inﬁltration into the CNS parenchyma and function as APCs to reactivate T cells in the CNS (Gallietal.,2011;Krausgruber et al.,2011).",
      "key": "340013fe2b6db5ea0662351efa735bee",
      "line": 330,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 58,
      "target": 27
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Upon detecting “danger” signals, both microglia and non-parenchymal macrophages produce large amounts of chemokines and cytokines to promote leukocyte inﬁltration into the CNS parenchyma and function as APCs to reactivate T cells in the CNS (Gallietal.,2011;Krausgruber et al.,2011).",
      "key": "b373df053fb2ba1ce6b1385d7cd96337",
      "line": 332,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 58,
      "target": 28
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "The activated monocyte-derived macrophages is generally considered to be harmful in MS (Yamasaki et al., 2014).",
      "key": "3cc061a523a09e08a09ab569938e19d8",
      "line": 558,
      "relation": "increases",
      "source": 58,
      "target": 138
    },
    {
      "annotations": {
        "Cell": {
          "leptomeningeal cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Leptomeningeal macrophages increase the expression of transforming growth factor-β in glial cells and cortical neurons by releasing prostaglandin E2 during inﬂammation (Wu et al., 2007).",
      "key": "05a38c28eb7c7da7715dd4d58287a2c7",
      "line": 729,
      "relation": "increases",
      "source": 58,
      "target": 6
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "These agents include ethyl pyruvate (Djedovi´c et al., 2017), spermidine (Yang et al., 2016), bryostatin-1(Kornbergetal.,2018),forskolin(Veremeykoetal., 2018), and lenalidomide (Weng et al., 2018).",
      "key": "0078c0f8a894718496073271ddb00c47",
      "line": 810,
      "relation": "association",
      "source": 58,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "These agents include ethyl pyruvate (Djedovi´c et al., 2017), spermidine (Yang et al., 2016), bryostatin-1(Kornbergetal.,2018),forskolin(Veremeykoetal., 2018), and lenalidomide (Weng et al., 2018).",
      "key": "15d1fb9ee613816e0c3d14d5b4be4b8d",
      "line": 811,
      "relation": "association",
      "source": 58,
      "target": 8
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "These agents include ethyl pyruvate (Djedovi´c et al., 2017), spermidine (Yang et al., 2016), bryostatin-1(Kornbergetal.,2018),forskolin(Veremeykoetal., 2018), and lenalidomide (Weng et al., 2018).",
      "key": "8400be3e1b0617c6a1d3a38beb67ff0f",
      "line": 812,
      "relation": "association",
      "source": 58,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "These agents include ethyl pyruvate (Djedovi´c et al., 2017), spermidine (Yang et al., 2016), bryostatin-1(Kornbergetal.,2018),forskolin(Veremeykoetal., 2018), and lenalidomide (Weng et al., 2018).",
      "key": "b7e7d6ab88488341bbc335c9199c0a8c",
      "line": 813,
      "relation": "association",
      "source": 58,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "These agents include ethyl pyruvate (Djedovi´c et al., 2017), spermidine (Yang et al., 2016), bryostatin-1(Kornbergetal.,2018),forskolin(Veremeykoetal., 2018), and lenalidomide (Weng et al., 2018).",
      "key": "f3ffc75748df1a9c0ff72b013dfbd469",
      "line": 814,
      "relation": "association",
      "source": 58,
      "target": 10
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Upon detecting “danger” signals, both microglia and non-parenchymal macrophages produce large amounts of chemokines and cytokines to promote leukocyte inﬁltration into the CNS parenchyma and function as APCs to reactivate T cells in the CNS (Gallietal.,2011;Krausgruber et al.,2011).",
      "key": "9935c947f2ba44d395c251b2a4759077",
      "line": 335,
      "object": {
        "location": {
          "name": "C74601",
          "namespace": "NCIT"
        }
      },
      "relation": "increases",
      "source": 27,
      "target": 18
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Chemokine gradients secreted from the CNS parenchyma can induce macrophage migration to the brain, making macrophages potential carriers for drug/nano formulations across the BBB to reach target sites (Ye et al., 2018).",
      "key": "a9c61812cde97d871cc609ffb9a80ed6",
      "line": 866,
      "object": {
        "location": {
          "name": "Brain",
          "namespace": "MESH"
        }
      },
      "relation": "increases",
      "source": 27,
      "subject": {
        "location": {
          "name": "C74601",
          "namespace": "NCIT"
        }
      },
      "target": 31
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Upon detecting “danger” signals, both microglia and non-parenchymal macrophages produce large amounts of chemokines and cytokines to promote leukocyte inﬁltration into the CNS parenchyma and function as APCs to reactivate T cells in the CNS (Gallietal.,2011;Krausgruber et al.,2011).",
      "key": "24f98a52f9ccf7fe823e01d8490a00bf",
      "line": 334,
      "object": {
        "location": {
          "name": "C74601",
          "namespace": "NCIT"
        }
      },
      "relation": "increases",
      "source": 28,
      "target": 18
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "These microglia are enriched with iron, express proinﬂammatory cytokines, and cause persistent tissue damage (Wisnieﬀ et al., 2015).",
      "key": "cc2c1c8914dc7d3918c3844ec42794ba",
      "line": 369,
      "relation": "increases",
      "source": 28,
      "target": 144
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "These microglia are enriched with iron, express proinﬂammatory cytokines, and cause persistent tissue damage (Wisnieﬀ et al., 2015).",
      "key": "02e978c8d25c76d685591c7d3858fabf",
      "line": 370,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 28,
      "target": 39
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Microglial activation may also be beneﬁcial for remyelination in MS due to the phagocytotic ability of microglia, as well as their secretion of neuroprotective molecules and antiinﬂammatory cytokines (Du et al., 2017).",
      "key": "3416335eb6b366e7a9cb14b0ffc44eda",
      "line": 489,
      "relation": "decreases",
      "source": 28,
      "target": 56
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Consistent with this, time-course studies in EAE mice showed that the appearance of inﬂammatory T cells in the CNS is consistent with the activation of CD11b+ microglia (Murphy et al., 2010).",
      "key": "40193a663b1e1639a5586648bdffdcd9",
      "line": 439,
      "relation": "increases",
      "source": 44,
      "target": 59
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Meninges": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "In concordance, meningeal macrophages are equipped to present peptide antigens to T cells, triggering neuroinﬂammatory events (Bartholomäus et al., 2009; Kivisakk et al., 2009; Ransohoﬀ and Cardona, 2010).",
      "key": "7b313779a41b881e02b8e0111b7d5a65",
      "line": 709,
      "relation": "increases",
      "source": 44,
      "target": 137
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "After CNS injury and inﬂammation, while microglia situated in the parenchyma and macrophages in the choroid plexus, perivascular space, and the meninges are activated, monocytes from the blood cross the damaged BBB and become monocyte derived macrophages in the CNS (Lassmann et al., 2001).",
      "key": "8f19036b4ddb2af1d628601c790171c2",
      "line": 344,
      "object": {
        "location": {
          "name": "C74601",
          "namespace": "NCIT"
        },
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 52,
      "target": 32
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "After CNS injury and inﬂammation, while microglia situated in the parenchyma and macrophages in the choroid plexus, perivascular space, and the meninges are activated, monocytes from the blood cross the damaged BBB and become monocyte derived macrophages in the CNS (Lassmann et al., 2001).",
      "key": "587892a19b18624caf36b56b536e4847",
      "line": 345,
      "object": {
        "location": {
          "name": "Choroid Plexus",
          "namespace": "MESH"
        },
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 52,
      "target": 31
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "After CNS injury and inﬂammation, while microglia situated in the parenchyma and macrophages in the choroid plexus, perivascular space, and the meninges are activated, monocytes from the blood cross the damaged BBB and become monocyte derived macrophages in the CNS (Lassmann et al., 2001).",
      "key": "9a92e25413ca03553f8b81f73ea7e329",
      "line": 346,
      "object": {
        "location": {
          "name": "C83196",
          "namespace": "NCIT"
        },
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 52,
      "target": 31
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "After CNS injury and inﬂammation, while microglia situated in the parenchyma and macrophages in the choroid plexus, perivascular space, and the meninges are activated, monocytes from the blood cross the damaged BBB and become monocyte derived macrophages in the CNS (Lassmann et al., 2001).",
      "key": "5cdbc17c516e561899a1dba9ca31f039",
      "line": 347,
      "object": {
        "location": {
          "name": "Meninges",
          "namespace": "MESH"
        },
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 52,
      "target": 31
    },
    {
      "key": "fcd3ce98fd63eadaed4cab4c709f2108",
      "relation": "partOf",
      "source": 5,
      "target": 32
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Activated microglia in EAE mice may produce large amounts of TNFα and thus induce excessive glutamate, leading to spontaneous and miniature excitatory post-synaptic currents (Centonze et al., 2009, 2010).",
      "key": "0c53931411bb78deb02c7c053914bd75",
      "line": 388,
      "relation": "increases",
      "source": 0,
      "target": 54
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Furthermore, astroglial ATP ampliﬁes microglial signals and subsequently promotes glutamate release from astroglia, which directly inhibits synaptic transmission (Kettenmann et al., 2013).",
      "key": "da0e0f6a7646f4f8eebf388374705da0",
      "line": 397,
      "relation": "directlyDecreases",
      "source": 0,
      "subject": {
        "location": {
          "name": "Synapses",
          "namespace": "MESH"
        }
      },
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Furthermore, astroglial ATP ampliﬁes microglial signals and subsequently promotes glutamate release from astroglia, which directly inhibits synaptic transmission (Kettenmann et al., 2013).",
      "key": "3cab8619aaa592e3a4130e163e091c80",
      "line": 395,
      "relation": "increases",
      "source": 1,
      "subject": {
        "location": {
          "name": "Astrocytes",
          "namespace": "MESH"
        }
      },
      "target": 59
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Classically activated neuroinﬂammatory microglia secrete TNF-α, and C1q, inducing A1 astrocyte dysfunction, thereby resulting in the dysfunction of both oligodendrocytes and neurons (Liddelow et al., 2017; Rothhammer et al., 2018).",
      "key": "74ab06179e3d5aeeee040fe7679e15c5",
      "line": 406,
      "object": {
        "modifier": "Activity"
      },
      "relation": "negativeCorrelation",
      "source": 86,
      "target": 26
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Classically activated neuroinﬂammatory microglia secrete TNF-α, and C1q, inducing A1 astrocyte dysfunction, thereby resulting in the dysfunction of both oligodendrocytes and neurons (Liddelow et al., 2017; Rothhammer et al., 2018).",
      "key": "587d37e5e8cff83ea0e19ee4f4428f5d",
      "line": 405,
      "relation": "negativeCorrelation",
      "source": 26,
      "subject": {
        "modifier": "Activity"
      },
      "target": 118
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Classically activated neuroinﬂammatory microglia secrete TNF-α, and C1q, inducing A1 astrocyte dysfunction, thereby resulting in the dysfunction of both oligodendrocytes and neurons (Liddelow et al., 2017; Rothhammer et al., 2018).",
      "key": "a309b03e7e79f38a088e911034bb768f",
      "line": 406,
      "relation": "negativeCorrelation",
      "source": 26,
      "subject": {
        "modifier": "Activity"
      },
      "target": 86
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Classically activated neuroinﬂammatory microglia secrete TNF-α, and C1q, inducing A1 astrocyte dysfunction, thereby resulting in the dysfunction of both oligodendrocytes and neurons (Liddelow et al., 2017; Rothhammer et al., 2018).",
      "key": "97120c91a22081181a710f20861a60ae",
      "line": 408,
      "object": {
        "modifier": "Activity"
      },
      "relation": "positiveCorrelation",
      "source": 26,
      "target": 34
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Classically activated neuroinﬂammatory microglia secrete TNF-α, and C1q, inducing A1 astrocyte dysfunction, thereby resulting in the dysfunction of both oligodendrocytes and neurons (Liddelow et al., 2017; Rothhammer et al., 2018).",
      "key": "5e3ee89d2e055940f6ffff186a37517c",
      "line": 409,
      "object": {
        "modifier": "Activity"
      },
      "relation": "positiveCorrelation",
      "source": 26,
      "target": 35
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Classically activated neuroinﬂammatory microglia secrete TNF-α, and C1q, inducing A1 astrocyte dysfunction, thereby resulting in the dysfunction of both oligodendrocytes and neurons (Liddelow et al., 2017; Rothhammer et al., 2018).",
      "key": "29d23255e14ee432cec83b6488295ca7",
      "line": 409,
      "relation": "positiveCorrelation",
      "source": 35,
      "subject": {
        "modifier": "Activity"
      },
      "target": 26
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Classically activated neuroinﬂammatory microglia secrete TNF-α, and C1q, inducing A1 astrocyte dysfunction, thereby resulting in the dysfunction of both oligodendrocytes and neurons (Liddelow et al., 2017; Rothhammer et al., 2018).",
      "key": "0924c907c90389ac9b33aa04f46a6150",
      "line": 411,
      "relation": "negativeCorrelation",
      "source": 35,
      "subject": {
        "modifier": "Activity"
      },
      "target": 60
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Importantly, mitochondrial disturbances have been demonstrated in modulating MS lesions,reactive oxygen species and reactive nitrogen species generated by the activated microglia also lead to intra-axonal mitochondrial injury (Balaban et al., 2005;Haileetal.,2017).",
      "key": "d8e20341ad205f9eb26fc3ecb8e2968b",
      "line": 417,
      "relation": "association",
      "source": 136,
      "target": 138
    },
    {
      "annotations": {
        "CellStructure": {
          "Axons": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Importantly, mitochondrial disturbances have been demonstrated in modulating MS lesions,reactive oxygen species and reactive nitrogen species generated by the activated microglia also lead to intra-axonal mitochondrial injury (Balaban et al., 2005;Haileetal.,2017).",
      "key": "6550051bd714e2367544c277f292f175",
      "line": 421,
      "relation": "increases",
      "source": 21,
      "target": 143
    },
    {
      "annotations": {
        "CellStructure": {
          "Axons": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Importantly, mitochondrial disturbances have been demonstrated in modulating MS lesions,reactive oxygen species and reactive nitrogen species generated by the activated microglia also lead to intra-axonal mitochondrial injury (Balaban et al., 2005;Haileetal.,2017).",
      "key": "143ffcbbf90b873f4a0c9f6ccbb7ae4a",
      "line": 422,
      "relation": "increases",
      "source": 20,
      "target": 143
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Kinetics studies from EAE mice indicate that microglia are the ﬁrst cell line to take up myelin antigens (Sosa et al., 2013), subsequently restimulating encephalitogenic T cells in the CNS through major histocompatibility complex (MHC) molecules and costimulatory molecules (Perry, 1998).",
      "key": "a35042772c54aeee2503298441a17d17",
      "line": 431,
      "relation": "increases",
      "source": 80,
      "target": 125
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Kinetics studies from EAE mice indicate that microglia are the ﬁrst cell line to take up myelin antigens (Sosa et al., 2013), subsequently restimulating encephalitogenic T cells in the CNS through major histocompatibility complex (MHC) molecules and costimulatory molecules (Perry, 1998).",
      "key": "22a77ed0dd31e4eceed73f8e2450c2cd",
      "line": 433,
      "relation": "increases",
      "source": 80,
      "target": 44
    },
    {
      "key": "0ed408194d84024c4ec2463f49638e20",
      "relation": "partOf",
      "source": 25,
      "target": 80
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Kinetics studies from EAE mice indicate that microglia are the ﬁrst cell line to take up myelin antigens (Sosa et al., 2013), subsequently restimulating encephalitogenic T cells in the CNS through major histocompatibility complex (MHC) molecules and costimulatory molecules (Perry, 1998).",
      "key": "06c37dea059e6b99a1b2941150ccea9a",
      "line": 432,
      "relation": "increases",
      "source": 125,
      "target": 44
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "However, speciﬁc deletion of MHCII in microglia does not aﬀect disease progression,suggesting that microglia are not important in reactivating eﬃcient T cells in the CNS (Wolf et al., 2018).",
      "key": "221ad7660683f985fe349b995f655655",
      "line": 446,
      "relation": "causesNoChange",
      "source": 128,
      "target": 138
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Microglia also secrete a series of pro-inﬂammatory cytokines such as IL-18, IL-6, and IL-1b and chemokines like CCL2 and CCL5 to aggravate both MS and EAE (Merson et al., 2010; Jiang et al., 2014).",
      "key": "bcefee27eb09dc38f2e7a7ae3dc90baf",
      "line": 458,
      "relation": "increases",
      "source": 107,
      "target": 56
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Microglia also secrete a series of pro-inﬂammatory cytokines such as IL-18, IL-6, and IL-1b and chemokines like CCL2 and CCL5 to aggravate both MS and EAE (Merson et al., 2010; Jiang et al., 2014).",
      "key": "91786da33a807a49cc4c30eb5e81c870",
      "line": 463,
      "relation": "increases",
      "source": 107,
      "target": 140
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Microglia also secrete a series of pro-inﬂammatory cytokines such as IL-18, IL-6, and IL-1b and chemokines like CCL2 and CCL5 to aggravate both MS and EAE (Merson et al., 2010; Jiang et al., 2014).",
      "key": "49e2260e7053c1291fec0f38256d6baa",
      "line": 460,
      "relation": "increases",
      "source": 109,
      "target": 56
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Microglia also secrete a series of pro-inﬂammatory cytokines such as IL-18, IL-6, and IL-1b and chemokines like CCL2 and CCL5 to aggravate both MS and EAE (Merson et al., 2010; Jiang et al., 2014).",
      "key": "c6bc5cfcad1b497f11140dd9bbdc42e6",
      "line": 465,
      "relation": "increases",
      "source": 109,
      "target": 140
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "IL-1β expression has been found to be pivotal in the polarization of Th17 cells and therefore for EAE induction (Sutton et al., 2006).",
      "key": "60045e6157479a4182d6b4b1da9d9251",
      "line": 598,
      "relation": "increases",
      "source": 109,
      "target": 140
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Microglia also secrete a series of pro-inﬂammatory cytokines such as IL-18, IL-6, and IL-1b and chemokines like CCL2 and CCL5 to aggravate both MS and EAE (Merson et al., 2010; Jiang et al., 2014).",
      "key": "2818edc1d633f32cc12907e77b9c0797",
      "line": 468,
      "relation": "increases",
      "source": 109,
      "target": 138
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "IL-1β expression has been found to be pivotal in the polarization of Th17 cells and therefore for EAE induction (Sutton et al., 2006).",
      "key": "ab1b4b918907b42eafdcc080712bb9c6",
      "line": 597,
      "relation": "positiveCorrelation",
      "source": 109,
      "target": 45
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Microglia also secrete a series of pro-inﬂammatory cytokines such as IL-18, IL-6, and IL-1b and chemokines like CCL2 and CCL5 to aggravate both MS and EAE (Merson et al., 2010; Jiang et al., 2014).",
      "key": "2dddf8ac506d47bff981bb6d11d9fe35",
      "line": 461,
      "relation": "increases",
      "source": 87,
      "target": 56
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Microglia also secrete a series of pro-inﬂammatory cytokines such as IL-18, IL-6, and IL-1b and chemokines like CCL2 and CCL5 to aggravate both MS and EAE (Merson et al., 2010; Jiang et al., 2014).",
      "key": "f181574d5950b5f8be6c1723a3de88bc",
      "line": 466,
      "relation": "increases",
      "source": 87,
      "target": 140
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Microglia also secrete a series of pro-inﬂammatory cytokines such as IL-18, IL-6, and IL-1b and chemokines like CCL2 and CCL5 to aggravate both MS and EAE (Merson et al., 2010; Jiang et al., 2014).",
      "key": "fa9835e0977ca6c65d037ff62813a9f6",
      "line": 470,
      "relation": "increases",
      "source": 87,
      "target": 138
    },
    {
      "annotations": {
        "Anatomy": {
          "perivascular space": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Furthermore, perivascular macrophages express high levels of adhesion molecules such as VCAM-1 and ICAM-1 and chemokines like CCL2 and CCL3 (Hofmann et al., 2002; Vercellino et al., 2017), which may mediated by chondroitin sulfate proteoglycans (Stephenson et al., 2018), to promote leukocyte inﬁltration into the CNS.",
      "key": "ea3d8c79c3739c660ce650b86093fa6a",
      "line": 693,
      "object": {
        "location": {
          "name": "Central Nervous System",
          "namespace": "MESH"
        }
      },
      "relation": "increases",
      "source": 87,
      "target": 18
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Inﬁltrating monocytes accumulate at the nodes of Ranvier during early stages of EAE and actively initiate the demyelination of axons (Yamasakietal.,2014), similar to microglia, but they do not aﬀect CNS-resident microglia (Ajami et al., 2011).",
      "key": "41591d06f19ef3dc10648b700600700f",
      "line": 563,
      "object": {
        "location": {
          "name": "node of Ranvier",
          "namespace": "GO"
        }
      },
      "relation": "increases",
      "source": 140,
      "target": 33
    },
    {
      "annotations": {
        "Anatomy": {
          "perivascular space": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Perivascular macrophages, typically CD163+HLADR+, are markedly increased in MS patients and EAE-aﬀected animals (Zhang et al., 2011; Mammana et al., 2018).",
      "key": "8fe080db2fe16e8585e4a41ddef00515",
      "line": 650,
      "relation": "increases",
      "source": 140,
      "target": 31
    },
    {
      "annotations": {
        "Anatomy": {
          "myelin": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Several receptors, including TREM2, complement receptor 3, and signal regulatory protein-α, invoke microglia to phagocytose myelin debris in lesions (Brendecke and Prinz, 2015).",
      "key": "62c76d414156735bac25cfbe3e0b823c",
      "line": 509,
      "object": {
        "modifier": "Degradation"
      },
      "relation": "increases",
      "source": 68,
      "target": 41
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Microglia-speciﬁc deletion of A20, the crucial protein in regulating microglial activation,makes microglia lose their ability to regulate neuronal synaptic function, thus exacerbating MS-like disease (Voet et al., 2018).",
      "key": "fa52d7cd08be160a765f16bd0bd6c4c4",
      "line": 495,
      "relation": "regulates",
      "source": 119,
      "target": 59
    },
    {
      "annotations": {
        "Cell": {
          "microglial cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Microglia-speciﬁc deletion of A20, the crucial protein in regulating microglial activation,makes microglia lose their ability to regulate neuronal synaptic function, thus exacerbating MS-like disease (Voet et al., 2018).",
      "key": "96f9e4f79440cc61671784be0978d1de",
      "line": 496,
      "relation": "regulates",
      "source": 119,
      "target": 74
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Microglia-speciﬁc deletion of A20, the crucial protein in regulating microglial activation,makes microglia lose their ability to regulate neuronal synaptic function, thus exacerbating MS-like disease (Voet et al., 2018).",
      "key": "98431a840b16184bcfbe9b13d954d322",
      "line": 498,
      "relation": "decreases",
      "source": 119,
      "target": 138
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Several receptors, including TREM2, complement receptor 3, and signal regulatory protein-α, invoke microglia to phagocytose myelin debris in lesions (Brendecke and Prinz, 2015).",
      "key": "2badf6ad7017e72c3a5791e1ebce83c6",
      "line": 504,
      "relation": "increases",
      "source": 122,
      "target": 59
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Microglia-speciﬁc ablation of TREM2 cannot upregulate genes associated with phagocytosis (Poliani et al., 2015), and the blockage of TREM2 results in increased demyelination in EAE (Piccio et al., 2007).",
      "key": "4fcd2764cf02c94c9501b67422e1f187",
      "line": 516,
      "relation": "decreases",
      "source": 122,
      "target": 141
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "In contrast to microglia, macrophages express TREM-1 rather than TREM-2,and although this isoform plays a role in inﬂammatory responses (Colonna and Facchetti,2003),the functions of TREM1 still need to be further studied in a CNS autoimmunity context.",
      "key": "43c8b368801be1076c8fb2b73a653a88",
      "line": 631,
      "relation": "association",
      "source": 122,
      "target": 144
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Several receptors, including TREM2, complement receptor 3, and signal regulatory protein-α, invoke microglia to phagocytose myelin debris in lesions (Brendecke and Prinz, 2015).",
      "key": "b9dd416eacbb0d736cdec02a60022c52",
      "line": 505,
      "relation": "increases",
      "source": 130,
      "target": 59
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Several receptors, including TREM2, complement receptor 3, and signal regulatory protein-α, invoke microglia to phagocytose myelin debris in lesions (Brendecke and Prinz, 2015).",
      "key": "050c13fd401c05d48894da4f0eb11232",
      "line": 506,
      "relation": "increases",
      "source": 116,
      "target": 59
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Moreover, microglia secrete trypsinogen, insulin-like growth factor, and ﬁbroblast growth factor during activation to promote neurogenesis (Pérez-Martín et al., 2010; Voss et al., 2012).",
      "key": "efba414d8ce231ea064f559301906fcb",
      "line": 525,
      "relation": "increases",
      "source": 83,
      "target": 67
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Moreover, microglia secrete trypsinogen, insulin-like growth factor, and ﬁbroblast growth factor during activation to promote neurogenesis (Pérez-Martín et al., 2010; Voss et al., 2012).",
      "key": "163f12458139958624c0529c1e70bab5",
      "line": 527,
      "relation": "increases",
      "source": 135,
      "target": 67
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Anti-inﬂammatory molecules from microglia also beneﬁt remyelination in EAE, for example, IL-4 enhances oligodendrogenesis (Butovsky et al., 2006), and activin A drives oligodendrocyte diﬀerentiation (Miron et al., 2013).",
      "key": "9cf7e2f1429584c9cfd81ee90dbb7365",
      "line": 537,
      "relation": "increases",
      "source": 132,
      "target": 62
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Anti-inﬂammatory molecules from microglia also beneﬁt remyelination in EAE, for example, IL-4 enhances oligodendrogenesis (Butovsky et al., 2006), and activin A drives oligodendrocyte diﬀerentiation (Miron et al., 2013).",
      "key": "8f19ccc8ec318802463848c0f73164d4",
      "line": 539,
      "relation": "decreases",
      "source": 132,
      "target": 56
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHDisease": {
          "Encephalomyelitis, Autoimmune, Experimental": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Anti-inﬂammatory molecules from microglia also beneﬁt remyelination in EAE, for example, IL-4 enhances oligodendrogenesis (Butovsky et al., 2006), and activin A drives oligodendrocyte diﬀerentiation (Miron et al., 2013).",
      "key": "7a2d49c923c2846005615c22fe20372d",
      "line": 541,
      "relation": "increases",
      "source": 132,
      "target": 78
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Interestingly, pro-inﬂammatory cytokine TNF has neuroprotective functions in EAE(Wolfetal.,2017),and deletion of microglial TNFR2 causing early disease onset, with increased leukocyte inﬁltration,demyelination and T cell activation in CNS (Gao et al., 2017).",
      "key": "7e4c1f3e948e7ae2e6588bedd0340e30",
      "line": 548,
      "relation": "decreases",
      "source": 120,
      "target": 140
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Interestingly, pro-inﬂammatory cytokine TNF has neuroprotective functions in EAE(Wolfetal.,2017),and deletion of microglial TNFR2 causing early disease onset, with increased leukocyte inﬁltration,demyelination and T cell activation in CNS (Gao et al., 2017).",
      "key": "3d28408cc3e2a03d07fb46955136d93d",
      "line": 550,
      "object": {
        "location": {
          "name": "Central Nervous System",
          "namespace": "MESH"
        }
      },
      "relation": "decreases",
      "source": 120,
      "target": 18
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Interestingly, pro-inﬂammatory cytokine TNF has neuroprotective functions in EAE(Wolfetal.,2017),and deletion of microglial TNFR2 causing early disease onset, with increased leukocyte inﬁltration,demyelination and T cell activation in CNS (Gao et al., 2017).",
      "key": "6aa6a791d97c217ce173d0f26a761c96",
      "line": 551,
      "relation": "decreases",
      "source": 120,
      "target": 141
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Interestingly, pro-inﬂammatory cytokine TNF has neuroprotective functions in EAE(Wolfetal.,2017),and deletion of microglial TNFR2 causing early disease onset, with increased leukocyte inﬁltration,demyelination and T cell activation in CNS (Gao et al., 2017).",
      "key": "6b6fdb6b91d8fb915139bcc02d05b948",
      "line": 552,
      "relation": "decreases",
      "source": 120,
      "target": 44
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Bone marrow chimeric mice show that TRPM2 expressed by CNS-inﬁltrating macrophages prompts the production of CXCL2, thus increasing neutrophil inﬁltration and contributing to the progression of EAE (Tsutsui et al., 2018).",
      "key": "94b4084f552b42da76e6fb58d6f5114d",
      "line": 574,
      "relation": "increases",
      "source": 123,
      "target": 98
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Macrophages also secrete large amounts of pro-inﬂammatory cytokines, such as IL6, IL-12, TNF-α, IL-1, and IL-23, to aggravate the inﬂammatory response (Valentin-Torres et al., 2016).",
      "key": "fa2f17a9f34c78766a1fd90fc4ae6cbe",
      "line": 591,
      "relation": "increases",
      "source": 105,
      "target": 144
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Macrophages also secrete large amounts of pro-inﬂammatory cytokines, such as IL6, IL-12, TNF-α, IL-1, and IL-23, to aggravate the inﬂammatory response (Valentin-Torres et al., 2016).",
      "key": "149b364a142f2642c05980f527319876",
      "line": 589,
      "relation": "increases",
      "source": 108,
      "target": 144
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "IL-1β expression has been found to be pivotal in the polarization of Th17 cells and therefore for EAE induction (Sutton et al., 2006).",
      "key": "f83ffa9a909e926d81902e78529b8b50",
      "line": 597,
      "relation": "positiveCorrelation",
      "source": 45,
      "target": 109
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "IL-6 has also been demonstrated to be critical for CNS autoimmunity, as IL6-deﬁcient mice demonstrated alleviated EAE (Samoilova et al., 1998).",
      "key": "7f239821c413828936f99ce83bb52493",
      "line": 604,
      "relation": "positiveCorrelation",
      "source": 142,
      "target": 111
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Macrophages also express high levels of CCR4 during the disease, and CCR4 deletion leading to reduced accumulation of macrophages in CNS and attenuated EAE symptoms(Fordeetal., 2011).",
      "key": "5176e1a507de5866b415e1ef7b6efbd0",
      "line": 615,
      "relation": "decreases",
      "source": 92,
      "target": 31
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        },
        "Disease": {
          "multiple sclerosis": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Macrophages also express high levels of CCR4 during the disease, and CCR4 deletion leading to reduced accumulation of macrophages in CNS and attenuated EAE symptoms(Fordeetal., 2011).",
      "key": "2f2c5ee444d6abef2a76c43c248e2daf",
      "line": 616,
      "relation": "increases",
      "source": 92,
      "target": 140
    },
    {
      "annotations": {
        "Cell": {
          "macrophage": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "The transcription factor Nr4a1 represses the autocrine production of nor epinephrine in macrophages,and myeloid cells lacking Nr4a1 lead to more leukocyte inﬁltration with in the CNS and more severe EAE clinical symptoms (Shaked et al., 2015).",
      "key": "43a3444445345037be43fdc4b6a7c2c8",
      "line": 637,
      "relation": "decreases",
      "source": 113,
      "target": 12
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Myeloid Cells": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "The transcription factor Nr4a1 represses the autocrine production of nor epinephrine in macrophages,and myeloid cells lacking Nr4a1 lead to more leukocyte inﬁltration with in the CNS and more severe EAE clinical symptoms (Shaked et al., 2015).",
      "key": "17bdfe3ada0fd15fae95d846831ba38f",
      "line": 640,
      "object": {
        "location": {
          "name": "Central Nervous System",
          "namespace": "MESH"
        }
      },
      "relation": "decreases",
      "source": 113,
      "target": 18
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "The transcription factor Nr4a1 represses the autocrine production of nor epinephrine in macrophages,and myeloid cells lacking Nr4a1 lead to more leukocyte inﬁltration with in the CNS and more severe EAE clinical symptoms (Shaked et al., 2015).",
      "key": "4d8167890f5e030542a4123227c74838",
      "line": 642,
      "relation": "decreases",
      "source": 113,
      "target": 140
    },
    {
      "annotations": {
        "Anatomy": {
          "perivascular space": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Meninges": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Selective elimination of both perivascular and meningeal macrophages by treatment with clodronate-loaded liposomes reduces the progression of EAE in rats (Polﬂiet et al., 2002), suggesting that perivascular macrophages may act as competent APCs in EAE.",
      "key": "e57113ee3a65519008669f46cf723e54",
      "line": 668,
      "relation": "decreases",
      "source": 3,
      "subject": {
        "location": {
          "name": "Liposomes",
          "namespace": "MESH"
        }
      },
      "target": 31
    },
    {
      "annotations": {
        "Anatomy": {
          "perivascular space": true
        },
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Meninges": true
        },
        "Species": {
          "10116": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Selective elimination of both perivascular and meningeal macrophages by treatment with clodronate-loaded liposomes reduces the progression of EAE in rats (Polﬂiet et al., 2002), suggesting that perivascular macrophages may act as competent APCs in EAE.",
      "key": "408be21a8e254d1374fcf16916712edb",
      "line": 669,
      "relation": "decreases",
      "source": 3,
      "subject": {
        "location": {
          "name": "Liposomes",
          "namespace": "MESH"
        }
      },
      "target": 140
    },
    {
      "annotations": {
        "Anatomy": {
          "perivascular space": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Furthermore, perivascular macrophages express high levels of adhesion molecules such as VCAM-1 and ICAM-1 and chemokines like CCL2 and CCL3 (Hofmann et al., 2002; Vercellino et al., 2017), which may mediated by chondroitin sulfate proteoglycans (Stephenson et al., 2018), to promote leukocyte inﬁltration into the CNS.",
      "key": "1809be5f9405f38a9aec052328a16827",
      "line": 691,
      "object": {
        "location": {
          "name": "Central Nervous System",
          "namespace": "MESH"
        }
      },
      "relation": "increases",
      "source": 124,
      "target": 18
    },
    {
      "annotations": {
        "Anatomy": {
          "perivascular space": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Furthermore, perivascular macrophages express high levels of adhesion molecules such as VCAM-1 and ICAM-1 and chemokines like CCL2 and CCL3 (Hofmann et al., 2002; Vercellino et al., 2017), which may mediated by chondroitin sulfate proteoglycans (Stephenson et al., 2018), to promote leukocyte inﬁltration into the CNS.",
      "key": "6d13697834c83f96a5d7e52c89afb2e6",
      "line": 692,
      "object": {
        "location": {
          "name": "Central Nervous System",
          "namespace": "MESH"
        }
      },
      "relation": "increases",
      "source": 100,
      "target": 18
    },
    {
      "annotations": {
        "Anatomy": {
          "perivascular space": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Furthermore, perivascular macrophages express high levels of adhesion molecules such as VCAM-1 and ICAM-1 and chemokines like CCL2 and CCL3 (Hofmann et al., 2002; Vercellino et al., 2017), which may mediated by chondroitin sulfate proteoglycans (Stephenson et al., 2018), to promote leukocyte inﬁltration into the CNS.",
      "key": "4fc2628efc7f092d84e38cb994cdb0b8",
      "line": 694,
      "object": {
        "location": {
          "name": "Central Nervous System",
          "namespace": "MESH"
        }
      },
      "relation": "increases",
      "source": 88,
      "target": 18
    },
    {
      "annotations": {
        "Anatomy": {
          "perivascular space": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Moreover, M2 perivascular macrophages can promote the diﬀerentiation of Th2 and Treg cells due to their anti-inﬂammatory characteristic (Weberetal.,2007).",
      "key": "789ab7667a3013461a4dce82c5211c12",
      "line": 700,
      "relation": "association",
      "source": 24,
      "target": 42
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Meninges": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "In contrast, meningeal macrophages produce neurotrophic and anti-inﬂammatory factors to inhibit leukocyte activity and their inﬁltration into the CNS at particular disease stages (Bogie et al., 2014).",
      "key": "22914c224e0fa711e92923401ae033a7",
      "line": 716,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 131,
      "target": 18
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Meninges": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "In contrast, meningeal macrophages produce neurotrophic and anti-inﬂammatory factors to inhibit leukocyte activity and their inﬁltration into the CNS at particular disease stages (Bogie et al., 2014).",
      "key": "c1d6b0461f4ec194dcabe7df69889f50",
      "line": 719,
      "object": {
        "location": {
          "name": "Central Nervous System",
          "namespace": "MESH"
        }
      },
      "relation": "decreases",
      "source": 131,
      "target": 18
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Meninges": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "In contrast, meningeal macrophages produce neurotrophic and anti-inﬂammatory factors to inhibit leukocyte activity and their inﬁltration into the CNS at particular disease stages (Bogie et al., 2014).",
      "key": "a82bbc03289b9cf5623f484d74819159",
      "line": 717,
      "object": {
        "modifier": "Activity"
      },
      "relation": "decreases",
      "source": 126,
      "target": 18
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Meninges": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "In contrast, meningeal macrophages produce neurotrophic and anti-inﬂammatory factors to inhibit leukocyte activity and their inﬁltration into the CNS at particular disease stages (Bogie et al., 2014).",
      "key": "1c624ad2ddcb2bdf270cbcd8ce1b8197",
      "line": 720,
      "object": {
        "location": {
          "name": "Central Nervous System",
          "namespace": "MESH"
        }
      },
      "relation": "decreases",
      "source": 126,
      "target": 18
    },
    {
      "annotations": {
        "Cell": {
          "leptomeningeal cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Leptomeningeal macrophages increase the expression of transforming growth factor-β in glial cells and cortical neurons by releasing prostaglandin E2 during inﬂammation (Wu et al., 2007).",
      "key": "2b7629b4c029c507a953212e6483c3b6",
      "line": 730,
      "object": {
        "location": {
          "name": "Neuroglia",
          "namespace": "MESH"
        }
      },
      "relation": "increases",
      "source": 6,
      "target": 117
    },
    {
      "annotations": {
        "Anatomy": {
          "cerebral cortex": true
        },
        "Cell": {
          "leptomeningeal cell": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Leptomeningeal macrophages increase the expression of transforming growth factor-β in glial cells and cortical neurons by releasing prostaglandin E2 during inﬂammation (Wu et al., 2007).",
      "key": "9b5f2e7e8137be55c8f6668750e1e005",
      "line": 732,
      "object": {
        "location": {
          "name": "Neurons",
          "namespace": "MESH"
        }
      },
      "relation": "increases",
      "source": 6,
      "target": 117
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "However, other studies demonstrated that prostaglandin E2 could also exacerbate EAE (Lima et al., 2012), depending on the disease stage and microenvironment.",
      "key": "5ded5bf64eef17c94b0f57df9f202a48",
      "line": 739,
      "relation": "increases",
      "source": 6,
      "target": 140
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "However, remote brain choroid plexus can also recruit M2-like macrophages to an injured spinal cord, which might beneﬁt myelin repair(Shechteretal.,2013).",
      "key": "6af2102d5cbee5b30e609d2465e1f288",
      "line": 760,
      "object": {
        "location": {
          "name": "Spinal Cord",
          "namespace": "MESH"
        }
      },
      "relation": "increases",
      "source": 16,
      "target": 42
    },
    {
      "annotations": {
        "Anatomy": {
          "myelin": true
        },
        "Confidence": {
          "High": true
        },
        "Species": {
          "10090": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Consistent with this, researchers found that mouse myelin macrophages could inhibit IFN-γ release by Th1 cells and suppress EAE severity (Bogie et al., 2014).",
      "key": "0c7077d99571931928080e58b0f5d3a2",
      "line": 768,
      "relation": "increases",
      "source": 23,
      "target": 102
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Currently, the clinical treatment of MS includes recombinant IFNβ-1a, glatiramer acetate, and natalizumab to mainly regulate T and B cells (Chengetal.,2017).",
      "key": "31f921cc10f3818d2c7dd0f39575aa48",
      "line": 789,
      "relation": "decreases",
      "source": 101,
      "target": 138
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Currently, the clinical treatment of MS includes recombinant IFNβ-1a, glatiramer acetate, and natalizumab to mainly regulate T and B cells (Chengetal.,2017).",
      "key": "588dbf6fe67bbb174748bbc106985765",
      "line": 792,
      "relation": "regulates",
      "source": 101,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Currently, the clinical treatment of MS includes recombinant IFNβ-1a, glatiramer acetate, and natalizumab to mainly regulate T and B cells (Chengetal.,2017).",
      "key": "8ece7a7a8aeb0fff38fd0c52da3ce2ba",
      "line": 795,
      "relation": "regulates",
      "source": 101,
      "target": 15
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Currently, the clinical treatment of MS includes recombinant IFNβ-1a, glatiramer acetate, and natalizumab to mainly regulate T and B cells (Chengetal.,2017).",
      "key": "a1efcaabf78f4cd05adac7410a4bb3c3",
      "line": 790,
      "relation": "decreases",
      "source": 17,
      "target": 138
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Currently, the clinical treatment of MS includes recombinant IFNβ-1a, glatiramer acetate, and natalizumab to mainly regulate T and B cells (Chengetal.,2017).",
      "key": "e5fab467b6655ea4b402016fa1df253f",
      "line": 793,
      "relation": "regulates",
      "source": 17,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Currently, the clinical treatment of MS includes recombinant IFNβ-1a, glatiramer acetate, and natalizumab to mainly regulate T and B cells (Chengetal.,2017).",
      "key": "f014c9282dc299ce970fc50504544a73",
      "line": 796,
      "relation": "regulates",
      "source": 17,
      "target": 15
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Studies have found that the neuroprotective eﬀects of glatiramer acetate are mediated by activated M2 microglia (Ratchford et al., 2012).",
      "key": "06530b2f8622fa686605935e8eaf6c78",
      "line": 804,
      "relation": "increases",
      "source": 17,
      "target": 77
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Currently, the clinical treatment of MS includes recombinant IFNβ-1a, glatiramer acetate, and natalizumab to mainly regulate T and B cells (Chengetal.,2017).",
      "key": "f0d82d234b7141f5d9394a9b4f4e39a8",
      "line": 791,
      "relation": "decreases",
      "source": 11,
      "target": 138
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Currently, the clinical treatment of MS includes recombinant IFNβ-1a, glatiramer acetate, and natalizumab to mainly regulate T and B cells (Chengetal.,2017).",
      "key": "a68347d6f98e67ece99be13b8e23a912",
      "line": 794,
      "relation": "regulates",
      "source": 11,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Currently, the clinical treatment of MS includes recombinant IFNβ-1a, glatiramer acetate, and natalizumab to mainly regulate T and B cells (Chengetal.,2017).",
      "key": "b3766e422e9ad156c825c48e7b849040",
      "line": 797,
      "relation": "regulates",
      "source": 11,
      "target": 15
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "These agents include ethyl pyruvate (Djedovi´c et al., 2017), spermidine (Yang et al., 2016), bryostatin-1(Kornbergetal.,2018),forskolin(Veremeykoetal., 2018), and lenalidomide (Weng et al., 2018).",
      "key": "fa31a1bf9065b6f938140dff473f840e",
      "line": 810,
      "relation": "association",
      "source": 9,
      "target": 58
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Ethyl pyruvate can reduce high-mobility group box 1 expression in activated ED1+ macrophages and Iba1+ microglia, thus inhibiting the activation of macrophages/microglia within the CNS to protect against EAE (Djedovi´c et al., 2017).",
      "key": "198e2a2742aa61778536b29d25685b46",
      "line": 826,
      "relation": "decreases",
      "source": 9,
      "target": 58
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "These agents include ethyl pyruvate (Djedovi´c et al., 2017), spermidine (Yang et al., 2016), bryostatin-1(Kornbergetal.,2018),forskolin(Veremeykoetal., 2018), and lenalidomide (Weng et al., 2018).",
      "key": "ff17280d17dcaf54fcc48aa0193a71b0",
      "line": 815,
      "relation": "association",
      "source": 9,
      "target": 59
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Ethyl pyruvate can reduce high-mobility group box 1 expression in activated ED1+ macrophages and Iba1+ microglia, thus inhibiting the activation of macrophages/microglia within the CNS to protect against EAE (Djedovi´c et al., 2017).",
      "key": "d59ca8c2d324e6d2841058dbbf621ea6",
      "line": 827,
      "relation": "decreases",
      "source": 9,
      "target": 59
    },
    {
      "annotations": {
        "Anatomy": {
          "central nervous system": true
        },
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "Ethyl pyruvate can reduce high-mobility group box 1 expression in activated ED1+ macrophages and Iba1+ microglia, thus inhibiting the activation of macrophages/microglia within the CNS to protect against EAE (Djedovi´c et al., 2017).",
      "key": "5776a6acd0b60c81ff3e273e924071ce",
      "line": 828,
      "relation": "decreases",
      "source": 9,
      "target": 140
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "These agents include ethyl pyruvate (Djedovi´c et al., 2017), spermidine (Yang et al., 2016), bryostatin-1(Kornbergetal.,2018),forskolin(Veremeykoetal., 2018), and lenalidomide (Weng et al., 2018).",
      "key": "1b1fab22ee1e7b2795f1444b5fdc5413",
      "line": 811,
      "relation": "association",
      "source": 8,
      "target": 58
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "These agents include ethyl pyruvate (Djedovi´c et al., 2017), spermidine (Yang et al., 2016), bryostatin-1(Kornbergetal.,2018),forskolin(Veremeykoetal., 2018), and lenalidomide (Weng et al., 2018).",
      "key": "3d3f4ba490bf820af1b30580901cb2ef",
      "line": 816,
      "relation": "association",
      "source": 8,
      "target": 59
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "These agents include ethyl pyruvate (Djedovi´c et al., 2017), spermidine (Yang et al., 2016), bryostatin-1(Kornbergetal.,2018),forskolin(Veremeykoetal., 2018), and lenalidomide (Weng et al., 2018).",
      "key": "3b8eff74632538cfcb9a4cd792067643",
      "line": 812,
      "relation": "association",
      "source": 2,
      "target": 58
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "These agents include ethyl pyruvate (Djedovi´c et al., 2017), spermidine (Yang et al., 2016), bryostatin-1(Kornbergetal.,2018),forskolin(Veremeykoetal., 2018), and lenalidomide (Weng et al., 2018).",
      "key": "203f298a9f385ffb9b132e5ba3c3796d",
      "line": 817,
      "relation": "association",
      "source": 2,
      "target": 59
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "These agents include ethyl pyruvate (Djedovi´c et al., 2017), spermidine (Yang et al., 2016), bryostatin-1(Kornbergetal.,2018),forskolin(Veremeykoetal., 2018), and lenalidomide (Weng et al., 2018).",
      "key": "1a76024a8ee8da0f389f013a1459a99d",
      "line": 813,
      "relation": "association",
      "source": 7,
      "target": 58
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "These agents include ethyl pyruvate (Djedovi´c et al., 2017), spermidine (Yang et al., 2016), bryostatin-1(Kornbergetal.,2018),forskolin(Veremeykoetal., 2018), and lenalidomide (Weng et al., 2018).",
      "key": "054d3392e1e90efc0c80ed01bae63f9e",
      "line": 818,
      "relation": "association",
      "source": 7,
      "target": 59
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "In addition, forskolin has been found to alleviate EAE by suppressing the expression of CD86 while enhancing the expression of ARG1 in macrophages (Veremeyko et al., 2018).",
      "key": "12cf93a0327a80362cf0b56415b9a21f",
      "line": 834,
      "relation": "decreases",
      "source": 7,
      "target": 93
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "In addition, forskolin has been found to alleviate EAE by suppressing the expression of CD86 while enhancing the expression of ARG1 in macrophages (Veremeyko et al., 2018).",
      "key": "31d2f6cb2e6fe7d2373b4de518db19a7",
      "line": 836,
      "relation": "decreases",
      "source": 7,
      "target": 140
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "In addition, forskolin has been found to alleviate EAE by suppressing the expression of CD86 while enhancing the expression of ARG1 in macrophages (Veremeyko et al., 2018).",
      "key": "987f7244fe6734f9e4cade686028061e",
      "line": 837,
      "object": {
        "location": {
          "name": "Macrophages",
          "namespace": "MESH"
        }
      },
      "relation": "increases",
      "source": 7,
      "target": 84
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "These agents include ethyl pyruvate (Djedovi´c et al., 2017), spermidine (Yang et al., 2016), bryostatin-1(Kornbergetal.,2018),forskolin(Veremeykoetal., 2018), and lenalidomide (Weng et al., 2018).",
      "key": "c5530a1bbdbacef00ac4683c9640a1f1",
      "line": 814,
      "relation": "association",
      "source": 10,
      "target": 58
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "These agents include ethyl pyruvate (Djedovi´c et al., 2017), spermidine (Yang et al., 2016), bryostatin-1(Kornbergetal.,2018),forskolin(Veremeykoetal., 2018), and lenalidomide (Weng et al., 2018).",
      "key": "60ef31c671dd14e8e47ca32548b529ff",
      "line": 819,
      "relation": "association",
      "source": 10,
      "target": 59
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "In addition, forskolin has been found to alleviate EAE by suppressing the expression of CD86 while enhancing the expression of ARG1 in macrophages (Veremeyko et al., 2018).",
      "key": "dc32803126503fe32350b586549d31bd",
      "line": 835,
      "relation": "increases",
      "source": 93,
      "target": 140
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "The long non-coding RNA GAS5, a suppresser of microglial M2 polarization, is expressed at a high level within microglia in MS patients.",
      "key": "a1fce71204ec3934a6d89df4a1db4aff",
      "line": 843,
      "relation": "decreases",
      "source": 146,
      "target": 32
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "For example, glucocorticoids are used extensively to treat acute relapses in MS patients (Pato-Pato et al., 2003; Cohen et al., 2009), but their therapeutic eﬀect is accompanied by serious side eﬀects due to their broad spectrum of immunosuppressive actions (Baschant and Tuckermann, 2010).",
      "key": "7c59508bf0e56c00faac4b4f4a2e15b9",
      "line": 849,
      "relation": "decreases",
      "source": 29,
      "target": 139
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        }
      },
      "citation": {
        "authors": [
          "He Q",
          "Wang J",
          "Weng Q",
          "Yang B"
        ],
        "date": "2019-01-01",
        "db": "PubMed",
        "db_id": "30967783",
        "db_name": "Targeting Microglia and Macrophages: A Potential Treatment Strategy for Multiple Sclerosis.",
        "first": "Wang J",
        "journal": "Frontiers in pharmacology",
        "last": "He Q",
        "pages": "286",
        "volume": "10"
      },
      "evidence": "For example, glucocorticoids are used extensively to treat acute relapses in MS patients (Pato-Pato et al., 2003; Cohen et al., 2009), but their therapeutic eﬀect is accompanied by serious side eﬀects due to their broad spectrum of immunosuppressive actions (Baschant and Tuckermann, 2010).",
      "key": "3bd89c7bc17f7d49562655575f8b5d59",
      "line": 850,
      "relation": "isA",
      "source": 29,
      "target": 4
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:\"2 L-glutamate\")",
      "concept": {
        "name": "2 L-glutamate",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "ddf17641cb0af8d3b77f3b0fc596fd3e"
    },
    {
      "bel": "a(CHEBI:\"adenosine triphosphate\")",
      "concept": {
        "name": "adenosine triphosphate",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "5df10c47733716e680d73b520cdc1918"
    },
    {
      "bel": "a(CHEBI:\"bryostatin 1\")",
      "concept": {
        "name": "bryostatin 1",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "c2b49667aada2c829e684246c825e20a"
    },
    {
      "bel": "a(CHEBI:\"clondronate(2-)\")",
      "concept": {
        "name": "clondronate(2-)",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "5ed39a203ff5d2b29d42dcbee13b2252"
    },
    {
      "bel": "a(CHEBI:\"immunosuppressive agent\")",
      "concept": {
        "name": "immunosuppressive agent",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "f813536ea7474c939e456e64c9be7a88"
    },
    {
      "bel": "a(CHEBI:\"iron atom\")",
      "concept": {
        "name": "iron atom",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "931dc3652ace8943c560ea954fe3d14d"
    },
    {
      "bel": "a(CHEBI:\"prostaglandin E2\")",
      "concept": {
        "name": "prostaglandin E2",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "c922120bcd2818906c2b9ad999a10bbc"
    },
    {
      "bel": "a(CHEBI:forskolin)",
      "concept": {
        "name": "forskolin",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "368e835a9701a4bf2db106251158741b"
    },
    {
      "bel": "a(CHEBI:spermidine)",
      "concept": {
        "name": "spermidine",
        "namespace": "CHEBI"
      },
      "function": "Abundance",
      "id": "3712200573dff247d44fe8430e582af4"
    },
    {
      "bel": "a(DRUGBANK:\"Ethyl pyruvate\")",
      "concept": {
        "name": "Ethyl pyruvate",
        "namespace": "DRUGBANK"
      },
      "function": "Abundance",
      "id": "af39b28e521b9e9bbf0e70f5fd4964b9"
    },
    {
      "bel": "a(DRUGBANK:Lenalidomide)",
      "concept": {
        "name": "Lenalidomide",
        "namespace": "DRUGBANK"
      },
      "function": "Abundance",
      "id": "f6a30a552d68b38df7ae7f79a80cd668"
    },
    {
      "bel": "a(DRUGBANK:Natalizumab)",
      "concept": {
        "name": "Natalizumab",
        "namespace": "DRUGBANK"
      },
      "function": "Abundance",
      "id": "aa5b6e671b82a62bbe1c8f71f964055a"
    },
    {
      "bel": "a(DRUGBANK:Norepinephrine)",
      "concept": {
        "name": "Norepinephrine",
        "namespace": "DRUGBANK"
      },
      "function": "Abundance",
      "id": "de6714b273affd7c22e21fed6ba8be1f"
    },
    {
      "bel": "a(GO:synapse)",
      "concept": {
        "name": "synapse",
        "namespace": "GO"
      },
      "function": "Abundance",
      "id": "69c474d54609b66889d95380bd3d9a19"
    },
    {
      "bel": "a(MESH:\"Antigen-Presenting Cells\")",
      "concept": {
        "name": "Antigen-Presenting Cells",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "8df8b36b26739aaa829426b306bfa1d7"
    },
    {
      "bel": "a(MESH:\"B-Lymphocytes\")",
      "concept": {
        "name": "B-Lymphocytes",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "f58463c9771eaea79cce530465284035"
    },
    {
      "bel": "a(MESH:\"Choroid Plexus\")",
      "concept": {
        "name": "Choroid Plexus",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "7f11b9f65f40f6f9ba0af733cff97bea"
    },
    {
      "bel": "a(MESH:\"Glatiramer Acetate\")",
      "concept": {
        "name": "Glatiramer Acetate",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "b04c825e3baa4d90dcd627d862c6ed6e"
    },
    {
      "bel": "a(MESH:\"Leukocytes, Mononuclear\")",
      "concept": {
        "name": "Leukocytes, Mononuclear",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "03db15c8be1d61caca141fdae3451b35"
    },
    {
      "bel": "a(MESH:\"Myelin Sheath\")",
      "concept": {
        "name": "Myelin Sheath",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "f05ef631e3e164921f592ca95e4976a4"
    },
    {
      "bel": "a(MESH:\"Reactive Nitrogen Species\")",
      "concept": {
        "name": "Reactive Nitrogen Species",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "4ea6b8f51189f9e4012e881745876d14"
    },
    {
      "bel": "a(MESH:\"Reactive Oxygen Species\")",
      "concept": {
        "name": "Reactive Oxygen Species",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "dd0e798c738472fa8ffb9fa88a2eacc7"
    },
    {
      "bel": "a(MESH:\"T-Lymphocytes\")",
      "concept": {
        "name": "T-Lymphocytes",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "04840e346c8f8e46d6d4e5ed8f1b84c5"
    },
    {
      "bel": "a(MESH:\"Th1 Cells\")",
      "concept": {
        "name": "Th1 Cells",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "556e55bb1bfab9908230d383616f04ed"
    },
    {
      "bel": "a(MESH:\"Th2 Cells\")",
      "concept": {
        "name": "Th2 Cells",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "f9aac88ef998325c524a95883639e711"
    },
    {
      "bel": "a(MESH:Antigens)",
      "concept": {
        "name": "Antigens",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "f8aec280b18d8c29378fa35631c2a000"
    },
    {
      "bel": "a(MESH:Astrocytes)",
      "concept": {
        "name": "Astrocytes",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "f02fc0f5c8a1ab66a9a7d9130d56d6fe"
    },
    {
      "bel": "a(MESH:Chemokines)",
      "concept": {
        "name": "Chemokines",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "9a02b9191c070440d07b7fd83cdc58e1"
    },
    {
      "bel": "a(MESH:Cytokines)",
      "concept": {
        "name": "Cytokines",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "0d3c01297f25a34285f54b350178a231"
    },
    {
      "bel": "a(MESH:Glucocorticoids)",
      "concept": {
        "name": "Glucocorticoids",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "f9bcc0ddc6d566c52744396122b75669"
    },
    {
      "bel": "a(MESH:Lipopolysaccharides)",
      "concept": {
        "name": "Lipopolysaccharides",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "0b34b10907bf7c8648aa171fc840a743"
    },
    {
      "bel": "a(MESH:Macrophages)",
      "concept": {
        "name": "Macrophages",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "311e39dad42597c983d7962f84ee92b6"
    },
    {
      "bel": "a(MESH:Microglia)",
      "concept": {
        "name": "Microglia",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "4ef490b325b2b1e33e41b4e22e1bd8c6"
    },
    {
      "bel": "a(MESH:Monocytes)",
      "concept": {
        "name": "Monocytes",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "cb51e019d107bf85f8e6744f36d4a5bb"
    },
    {
      "bel": "a(MESH:Neurons)",
      "concept": {
        "name": "Neurons",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "c429b8780142c504cf23cacfc2fa2b09"
    },
    {
      "bel": "a(MESH:Oligodendroglia)",
      "concept": {
        "name": "Oligodendroglia",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "828404c8a29719c3b6437908364a6ddd"
    },
    {
      "bel": "a(MESH:Parasites)",
      "concept": {
        "name": "Parasites",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "cb600340a0a849a086960c4e97b5a82a"
    },
    {
      "bel": "a(MESH:Pericytes)",
      "concept": {
        "name": "Pericytes",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "26f6aa66715f5dc5c0d272c26b4dde3a"
    },
    {
      "bel": "a(MESH:Phagocytes)",
      "concept": {
        "name": "Phagocytes",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "bf1fe3517e6fc85a24ce09919a1811c4"
    },
    {
      "bel": "a(MESH:Tissues)",
      "concept": {
        "name": "Tissues",
        "namespace": "MESH"
      },
      "function": "Abundance",
      "id": "892d2cfb80cbe3b7162d067f014e8ad0"
    },
    {
      "bel": "a(NCIT:C118474)",
      "concept": {
        "name": "C118474",
        "namespace": "NCIT"
      },
      "function": "Abundance",
      "id": "a636531bd132534f9dbdda2e5f4f8510"
    },
    {
      "bel": "a(NCIT:C120869)",
      "concept": {
        "name": "C120869",
        "namespace": "NCIT"
      },
      "function": "Abundance",
      "id": "a0776034b12dedb8f4bc428b33c6413a"
    },
    {
      "bel": "a(NCIT:C123783)",
      "concept": {
        "name": "C123783",
        "namespace": "NCIT"
      },
      "function": "Abundance",
      "id": "27a697f98cba67bd4ade5210b947e9f4"
    },
    {
      "bel": "a(NCIT:C156004)",
      "concept": {
        "name": "C156004",
        "namespace": "NCIT"
      },
      "function": "Abundance",
      "id": "abe18688335c397e8ddd68136a7ff16a"
    },
    {
      "bel": "bp(GO:\"T cell activation\")",
      "concept": {
        "name": "T cell activation",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "6475795284a1f1c537342febd590bb31"
    },
    {
      "bel": "bp(GO:\"T-helper 17 cell chemotaxis\")",
      "concept": {
        "name": "T-helper 17 cell chemotaxis",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "3d3ff837e2645b1736842ef75bf888dc"
    },
    {
      "bel": "bp(GO:\"apoptotic cell clearance\")",
      "concept": {
        "name": "apoptotic cell clearance",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "497d3a9705b2905b3c76744ba9c792fe"
    },
    {
      "bel": "bp(GO:\"brain development\")",
      "concept": {
        "name": "brain development",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "ac0c7c6bcd68b7fc8d43fa1e094e68f6"
    },
    {
      "bel": "bp(GO:\"cellular response to stress\")",
      "concept": {
        "name": "cellular response to stress",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "4b4228e207b3004b2cf3c07896ae1c8a"
    },
    {
      "bel": "bp(GO:\"cerebrospinal fluid circulation\")",
      "concept": {
        "name": "cerebrospinal fluid circulation",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "01cccf757e7b6f7f8d47347606251b5f"
    },
    {
      "bel": "bp(GO:\"cerebrospinal fluid secretion\")",
      "concept": {
        "name": "cerebrospinal fluid secretion",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "406fe004bd481ebbd95d54099ba711d6"
    },
    {
      "bel": "bp(GO:\"complement activation\")",
      "concept": {
        "name": "complement activation",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "c81d3c1b4b64cb916f209952fea071e6"
    },
    {
      "bel": "bp(GO:\"detection of wounding\")",
      "concept": {
        "name": "detection of wounding",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "2bf453445ed5e1fce2c9a4e00735873c"
    },
    {
      "bel": "bp(GO:\"establishment of blood-brain barrier\")",
      "concept": {
        "name": "establishment of blood-brain barrier",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "c3014893df4d7debb8c78dc9ea16046b"
    },
    {
      "bel": "bp(GO:\"excitatory postsynaptic potential\")",
      "concept": {
        "name": "excitatory postsynaptic potential",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "425b3bdbafda22a61082df748ee108b2"
    },
    {
      "bel": "bp(GO:\"generation of neurons\")",
      "concept": {
        "name": "generation of neurons",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "0df1f54487a90beeac83692bb406f5a0"
    },
    {
      "bel": "bp(GO:\"inflammatory response\")",
      "concept": {
        "name": "inflammatory response",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "abd32f6c5cca606061975532840db260"
    },
    {
      "bel": "bp(GO:\"learning or memory\")",
      "concept": {
        "name": "learning or memory",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "f7990d886000f2ae69441a960a7d6236"
    },
    {
      "bel": "bp(GO:\"macrophage activation\")",
      "concept": {
        "name": "macrophage activation",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "b4f30b2d638992803651eb8bd038b5e6"
    },
    {
      "bel": "bp(GO:\"microglial cell activation\")",
      "concept": {
        "name": "microglial cell activation",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "3c02f523866973a040dc6bfa5b372b2e"
    },
    {
      "bel": "bp(GO:\"neuroinflammatory response\")",
      "concept": {
        "name": "neuroinflammatory response",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "6e2a3e6619ccd33f9e976253c861dbb6"
    },
    {
      "bel": "bp(GO:\"oligodendrocyte development\")",
      "concept": {
        "name": "oligodendrocyte development",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "a010b71f27eb47e233435cc68a6d7a0e"
    },
    {
      "bel": "bp(GO:\"oligodendrocyte differentiation\")",
      "concept": {
        "name": "oligodendrocyte differentiation",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "12a55344b9cf1428f955054862b1629e"
    },
    {
      "bel": "bp(GO:\"regulatory T cell differentiation\")",
      "concept": {
        "name": "regulatory T cell differentiation",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "19cd3e927d6cce49626dc1ca2958a82f"
    },
    {
      "bel": "bp(GO:\"tissue remodeling\")",
      "concept": {
        "name": "tissue remodeling",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "4f6db4b117801ea769bdc2a1a5e68586"
    },
    {
      "bel": "bp(GO:angiogenesis)",
      "concept": {
        "name": "angiogenesis",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "3d6fd378871feec80135a583c419e7f1"
    },
    {
      "bel": "bp(GO:cognition)",
      "concept": {
        "name": "cognition",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "24220ec2073c35bcd945681ee9c6ea38"
    },
    {
      "bel": "bp(GO:neurogenesis)",
      "concept": {
        "name": "neurogenesis",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "a6081bcfdb54d676fc8fec30c017475f"
    },
    {
      "bel": "bp(GO:phagocytosis)",
      "concept": {
        "name": "phagocytosis",
        "namespace": "GO"
      },
      "function": "BiologicalProcess",
      "id": "7a964edef32244471f3c9f79c2cdfbaf"
    },
    {
      "bel": "bp(MESH:\"Adaptive Immunity\")",
      "concept": {
        "name": "Adaptive Immunity",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "79a63eee9cdc077e74d464de3d03ae28"
    },
    {
      "bel": "bp(MESH:\"Cell Survival\")",
      "concept": {
        "name": "Cell Survival",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "c6f26bea83787c63169a3fcb728da799"
    },
    {
      "bel": "bp(MESH:\"Neural Pathways\")",
      "concept": {
        "name": "Neural Pathways",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "ad574217ba100cc2e63a49b7cc42cdd7"
    },
    {
      "bel": "bp(MESH:\"Neuronal Plasticity\")",
      "concept": {
        "name": "Neuronal Plasticity",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "7e5d48cf7a27a09a15d969d961c71347"
    },
    {
      "bel": "bp(MESH:\"Neutrophil Infiltration\")",
      "concept": {
        "name": "Neutrophil Infiltration",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "67bdc0679ae70eaf5c25fcda1df9c3c5"
    },
    {
      "bel": "bp(MESH:\"Synaptic Potentials\")",
      "concept": {
        "name": "Synaptic Potentials",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "849d9590fe335e6065fea7c36de23239"
    },
    {
      "bel": "bp(MESH:Homeostasis)",
      "concept": {
        "name": "Homeostasis",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "99c9318d8be8f203ea33062e82abc333"
    },
    {
      "bel": "bp(MESH:Immunity)",
      "concept": {
        "name": "Immunity",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "9e0bf623f2590a960b619d224ef1381a"
    },
    {
      "bel": "bp(MESH:Neuroprotection)",
      "concept": {
        "name": "Neuroprotection",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "94345c5831649e39b0f93286f5357249"
    },
    {
      "bel": "bp(MESH:Remyelination)",
      "concept": {
        "name": "Remyelination",
        "namespace": "MESH"
      },
      "function": "BiologicalProcess",
      "id": "79abdcab21f9bd75b3078b78620119b0"
    },
    {
      "bel": "bp(NCIT:C53611)",
      "concept": {
        "name": "C53611",
        "namespace": "NCIT"
      },
      "function": "BiologicalProcess",
      "id": "6f73cc488e6f6881e2b57d6d6f5b72e6"
    },
    {
      "bel": "complex(a(MESH:Antigens), a(MESH:Microglia))",
      "function": "Complex",
      "id": "aed26962cd39920e8fb5a91a0244a313",
      "members": [
        {
          "bel": "a(MESH:Antigens)",
          "concept": {
            "name": "Antigens",
            "namespace": "MESH"
          },
          "function": "Abundance",
          "id": "f8aec280b18d8c29378fa35631c2a000"
        },
        {
          "bel": "a(MESH:Microglia)",
          "concept": {
            "name": "Microglia",
            "namespace": "MESH"
          },
          "function": "Abundance",
          "id": "4ef490b325b2b1e33e41b4e22e1bd8c6"
        }
      ]
    },
    {
      "bel": "complex(p(HGNC:CX3CL1), p(HGNC:CX3CR1))",
      "function": "Complex",
      "id": "0162984d9556fe0974518e044b351a17",
      "members": [
        {
          "bel": "p(HGNC:CX3CL1)",
          "concept": {
            "name": "CX3CL1",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "ac3d363f81abcfdfdb31b57252011a47"
        },
        {
          "bel": "p(HGNC:CX3CR1)",
          "concept": {
            "name": "CX3CR1",
            "namespace": "HGNC"
          },
          "function": "Protein",
          "id": "9945cf7492b5fe7f76faadee3f2ad481"
        }
      ]
    },
    {
      "bel": "composite(a(MESH:Microglia), a(MESH:Neurons))",
      "function": "Composite",
      "id": "f58bfa4de0523a53ffed56172ca53aad",
      "members": [
        {
          "bel": "a(MESH:Microglia)",
          "concept": {
            "name": "Microglia",
            "namespace": "MESH"
          },
          "function": "Abundance",
          "id": "4ef490b325b2b1e33e41b4e22e1bd8c6"
        },
        {
          "bel": "a(MESH:Neurons)",
          "concept": {
            "name": "Neurons",
            "namespace": "MESH"
          },
          "function": "Abundance",
          "id": "c429b8780142c504cf23cacfc2fa2b09"
        }
      ]
    },
    {
      "bel": "g(HGNC:PRSS3P2)",
      "concept": {
        "name": "PRSS3P2",
        "namespace": "HGNC"
      },
      "function": "Gene",
      "id": "2dad77376eba93758e49764d4652cfe0"
    },
    {
      "bel": "p(HGNC:ARG1)",
      "concept": {
        "name": "ARG1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "5416b564f91296a9bf4f568a38766b9d"
    },
    {
      "bel": "p(HGNC:BDNF)",
      "concept": {
        "name": "BDNF",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "a638d5f84b9678f17c8795852300134a"
    },
    {
      "bel": "p(HGNC:C1QA)",
      "concept": {
        "name": "C1QA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "434b684ae308fe9386a9998e2b8882b9"
    },
    {
      "bel": "p(HGNC:CCL2)",
      "concept": {
        "name": "CCL2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "2a1fddd8526478c2c7edadaa639bbe85"
    },
    {
      "bel": "p(HGNC:CCL3)",
      "concept": {
        "name": "CCL3",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "5cf35694ebdc37f754621a1d29763a9c"
    },
    {
      "bel": "p(HGNC:CCL4)",
      "concept": {
        "name": "CCL4",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "9cf87e6e1c70343068aa2e4dd8b737e8"
    },
    {
      "bel": "p(HGNC:CCL5)",
      "concept": {
        "name": "CCL5",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "a0cdee489437dd28b3d23c2f3abe9862"
    },
    {
      "bel": "p(HGNC:CCL8)",
      "concept": {
        "name": "CCL8",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "3ebf993dbf8e7595607f67e03d329046"
    },
    {
      "bel": "p(HGNC:CCR4)",
      "concept": {
        "name": "CCR4",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "8f8c85c05ac5a56c4a61b51bedf5f120"
    },
    {
      "bel": "p(HGNC:CD86)",
      "concept": {
        "name": "CD86",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "2749ceafce8a4322524f97a902295d82"
    },
    {
      "bel": "p(HGNC:CSF1R)",
      "concept": {
        "name": "CSF1R",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "cea919ed34a062e3a745af78301f947f"
    },
    {
      "bel": "p(HGNC:CX3CL1)",
      "concept": {
        "name": "CX3CL1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "ac3d363f81abcfdfdb31b57252011a47"
    },
    {
      "bel": "p(HGNC:CX3CR1)",
      "concept": {
        "name": "CX3CR1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "9945cf7492b5fe7f76faadee3f2ad481"
    },
    {
      "bel": "p(HGNC:CXCL10)",
      "concept": {
        "name": "CXCL10",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "fd9a90dd7c73cd8dc9d99b88ac8aab1e"
    },
    {
      "bel": "p(HGNC:CXCL2)",
      "concept": {
        "name": "CXCL2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "ab9bf6571b49dd320bc16e86046b0444"
    },
    {
      "bel": "p(HGNC:CXCL9)",
      "concept": {
        "name": "CXCL9",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "c05f89a6141199866dc090939b690365"
    },
    {
      "bel": "p(HGNC:ICAM1)",
      "concept": {
        "name": "ICAM1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "7f17c7170f0c093409f8f0505f248b50"
    },
    {
      "bel": "p(HGNC:IFNB1)",
      "concept": {
        "name": "IFNB1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "187da957c4e0c092e01fc85dd9da5fa4"
    },
    {
      "bel": "p(HGNC:IFNG)",
      "concept": {
        "name": "IFNG",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "20367a6ea54ae1032be4f48276f3c524"
    },
    {
      "bel": "p(HGNC:IGF1)",
      "concept": {
        "name": "IGF1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "4089131c84500a626f3306507fbf4b11"
    },
    {
      "bel": "p(HGNC:IL10)",
      "concept": {
        "name": "IL10",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "e0c41f4b3cb8bef32af4e3217ba8aa12"
    },
    {
      "bel": "p(HGNC:IL12B)",
      "concept": {
        "name": "IL12B",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "60dbcf5bfd39cff30cca20dce8691ea4"
    },
    {
      "bel": "p(HGNC:IL13)",
      "concept": {
        "name": "IL13",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "148a1f49575f988c19d1ea5763eedfd0"
    },
    {
      "bel": "p(HGNC:IL18)",
      "concept": {
        "name": "IL18",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "3021445282aa1070b485fa7febe4d063"
    },
    {
      "bel": "p(HGNC:IL1A)",
      "concept": {
        "name": "IL1A",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "017f14e3a15a95b856bdaba5630dcf34"
    },
    {
      "bel": "p(HGNC:IL1B)",
      "concept": {
        "name": "IL1B",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "cca08112d9fcf1a31015f1dbfc30b04c"
    },
    {
      "bel": "p(HGNC:IL4)",
      "concept": {
        "name": "IL4",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "4bf986cc68574441e53aac56e3621b28"
    },
    {
      "bel": "p(HGNC:IL6)",
      "concept": {
        "name": "IL6",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "8a1d3c4828c5416eba867c395cc65caa"
    },
    {
      "bel": "p(HGNC:NOS2)",
      "concept": {
        "name": "NOS2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "65765ae76206b40d993591e8b138acd4"
    },
    {
      "bel": "p(HGNC:NR4A1)",
      "concept": {
        "name": "NR4A1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "c89bcdb399b8a69a0b317284aeb07361"
    },
    {
      "bel": "p(HGNC:NTRK2)",
      "concept": {
        "name": "NTRK2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "5873dc57711d54aff73ef2aa04a42017"
    },
    {
      "bel": "p(HGNC:PF4)",
      "concept": {
        "name": "PF4",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "2ae8fc80ae85e96e3f96f7317a038e27"
    },
    {
      "bel": "p(HGNC:SRPRA)",
      "concept": {
        "name": "SRPRA",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "f9a7e9107e794d24452c270537242993"
    },
    {
      "bel": "p(HGNC:TGFB1)",
      "concept": {
        "name": "TGFB1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "f1f493c4771241860fc73aaa3bfdad66"
    },
    {
      "bel": "p(HGNC:TNF)",
      "concept": {
        "name": "TNF",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "fdc1c1f5a73c3c992b6eb71ce9b6908e"
    },
    {
      "bel": "p(HGNC:TNFAIP3)",
      "concept": {
        "name": "TNFAIP3",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "bc1b293cfdd5cdaad43377a82e8844ae"
    },
    {
      "bel": "p(HGNC:TNFRSF1B)",
      "concept": {
        "name": "TNFRSF1B",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "1129f030029c60cf84a21fea273843ff"
    },
    {
      "bel": "p(HGNC:TREM1)",
      "concept": {
        "name": "TREM1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "4ff4e70c5b7bb1d69a5b35fe52fa859e"
    },
    {
      "bel": "p(HGNC:TREM2)",
      "concept": {
        "name": "TREM2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "c3044030c371598598bb85b0321d03ea"
    },
    {
      "bel": "p(HGNC:TRPM2)",
      "concept": {
        "name": "TRPM2",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "40959c3e0ab593596fb98ca74cff5959"
    },
    {
      "bel": "p(HGNC:VCAM1)",
      "concept": {
        "name": "VCAM1",
        "namespace": "HGNC"
      },
      "function": "Protein",
      "id": "1f8295903afe529c3261018587ec7a88"
    },
    {
      "bel": "p(HGNCGENEFAMILY:\"Histocompatibility complex\")",
      "concept": {
        "name": "Histocompatibility complex",
        "namespace": "HGNCGENEFAMILY"
      },
      "function": "Protein",
      "id": "3d152370eff0617f44e6b9a446bc410b"
    },
    {
      "bel": "p(MESH:\"Anti-Inflammatory Agents\")",
      "concept": {
        "name": "Anti-Inflammatory Agents",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "39ceaf2c903adfe898635be654e78942"
    },
    {
      "bel": "p(MESH:\"Fibroblast Growth Factors\")",
      "concept": {
        "name": "Fibroblast Growth Factors",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "8e0e96d1dd7b58f26657f95e15ad8977"
    },
    {
      "bel": "p(MESH:\"Histocompatibility Antigens Class II\")",
      "concept": {
        "name": "Histocompatibility Antigens Class II",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "6abe1e39696f855773e1cdc75ca50d00"
    },
    {
      "bel": "p(MESH:\"Interleukin-23\")",
      "concept": {
        "name": "Interleukin-23",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "52cca75564f0f8d46c5e1912bf3a8560"
    },
    {
      "bel": "p(MESH:\"Macrophage-1 Antigen\")",
      "concept": {
        "name": "Macrophage-1 Antigen",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "f0207341260ad981bc737ba0eddc6142"
    },
    {
      "bel": "p(MESH:\"Nerve Growth Factors\")",
      "concept": {
        "name": "Nerve Growth Factors",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "174ffd335e7ddb48d5851ca013e92344"
    },
    {
      "bel": "p(MESH:Activins)",
      "concept": {
        "name": "Activins",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "5f9dd8697c261d842430b901b585a6b6"
    },
    {
      "bel": "p(MESH:Proteins)",
      "concept": {
        "name": "Proteins",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "5f95843f75d793290da323632314ec25"
    },
    {
      "bel": "p(MESH:Proteins, pmod(CONSO:misfolded))",
      "concept": {
        "name": "Proteins",
        "namespace": "MESH"
      },
      "function": "Protein",
      "id": "b1b334ae55bd6774ab33678dc48e7bd6",
      "variants": [
        {
          "concept": {
            "name": "misfolded",
            "namespace": "CONSO"
          },
          "kind": "pmod"
        }
      ]
    },
    {
      "bel": "p(NCIT:C20426)",
      "concept": {
        "name": "C20426",
        "namespace": "NCIT"
      },
      "function": "Protein",
      "id": "86eb2713cf3bd9d26bd61d372209b1f2"
    },
    {
      "bel": "path(CONSO:\"mitochondrial dysfunction\")",
      "concept": {
        "name": "mitochondrial dysfunction",
        "namespace": "CONSO"
      },
      "function": "Pathology",
      "id": "14a330b2e354b7af4f380b05664a5728"
    },
    {
      "bel": "path(CONSO:neuroinflammation)",
      "concept": {
        "name": "neuroinflammation",
        "namespace": "CONSO"
      },
      "function": "Pathology",
      "id": "b264621022ed4df78748c6c4e198145d"
    },
    {
      "bel": "path(DOID:\"multiple sclerosis\")",
      "concept": {
        "name": "multiple sclerosis",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "828e65d53fe5c29b364f79cfd5304f90"
    },
    {
      "bel": "path(DOID:\"relapsing-remitting multiple sclerosis\")",
      "concept": {
        "name": "relapsing-remitting multiple sclerosis",
        "namespace": "DOID"
      },
      "function": "Pathology",
      "id": "b21b34dd5c948d6330eceb5f4eb9649f"
    },
    {
      "bel": "path(EFO:\"experimental autoimmune encephalomyelitis\")",
      "concept": {
        "name": "experimental autoimmune encephalomyelitis",
        "namespace": "EFO"
      },
      "function": "Pathology",
      "id": "32b1c17fbec51b6b7c44e27150d888c7"
    },
    {
      "bel": "path(HP:\"CNS demyelination\")",
      "concept": {
        "name": "CNS demyelination",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "fb7670f43e6511eda6fbd0b0517820a6"
    },
    {
      "bel": "path(HP:Autoimmunity)",
      "concept": {
        "name": "Autoimmunity",
        "namespace": "HP"
      },
      "function": "Pathology",
      "id": "a7fdebc3336d7daf8fa61b75a73d9fb0"
    },
    {
      "bel": "path(MESH:\"Mitochondrial Degradation\")",
      "concept": {
        "name": "Mitochondrial Degradation",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "2f27c1ec240d03ed87d4290de5647881"
    },
    {
      "bel": "path(MESH:Inflammation)",
      "concept": {
        "name": "Inflammation",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "10cd96fd4056a5e6c27264e0130e89f9"
    },
    {
      "bel": "path(MESH:Light)",
      "concept": {
        "name": "Light",
        "namespace": "MESH"
      },
      "function": "Pathology",
      "id": "1d49c5a3e336902e8e327ddcd28f3376"
    },
    {
      "bel": "r(HGNC:GAS5)",
      "concept": {
        "name": "GAS5",
        "namespace": "HGNC"
      },
      "function": "RNA",
      "id": "b4608d4d97b538910e6f763c4933567a"
    }
  ]
}